Next Article in Journal
Functionalities of Gelatin Modified with 2-Octenyl Succinic Anhydride and Gallic Acid
Next Article in Special Issue
Moringa oleifera Seeds Characterization and Potential Uses as Food
Previous Article in Journal
Toxicity, Antioxidant Activity, and Phytochemicals of Basil (Ocimum basilicum L.) Leaves Cultivated in Southern Punjab, Pakistan
Previous Article in Special Issue
Phenolics Profile and Protective Effect on Injuried HUVEC Cells of Epicarp Extracts from Kadsura coccinea
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Foods
Volume 11
Issue 9
10.3390/foods11091240
foods-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

An Overview of Traditional Uses, Phytochemical Compositions and Biological Activities of Edible Fruits of European and Asian Cornus Species

by
Maria C. Tenuta
1,2,
Brigitte Deguin
2,*,
Monica R. Loizzo
1,
Claire Cuyamendous
2,
Marco Bonesi
1,
Vincenzo Sicari
3,
Lorenza Trabalzini
4,
Anne-Claire Mitaine-Offer
5,
Jianbo Xiao
6,7 and
Rosa Tundis
1
1
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy
2
Faculté de Pharmacie de Paris, Université Paris Cité, U.M.R. n°8038-CiTCoM-(CNRS, Université de Paris Cité), F-75006 Paris, France
3
Department of Agraria, “Mediterranea” University of Reggio Calabria, 89124 Reggio Calabria, Italy
4
Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy
5
Centre des Sciences du Goût et de l’Alimentation, CNRS, INRAE, Institut Agro, Laboratoire de Pharmacognosie, UFR des Sciences de Santé, Université de Bourgogne Franche-Comté, BP 87900, CEDEX, F-21079 Dijon, France
6
Nutrition and Bromatology Group, Analytical and Food Chemistry Department, Faculty of Food Science and Technology, Universidade de Vigo, Ourense Campus, E-32004 Ourense, Spain
7
School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China
*
Author to whom correspondence should be addressed.
Foods 2022, 11(9), 1240; https://doi.org/10.3390/foods11091240
Submission received: 30 March 2022 / Revised: 16 April 2022 / Accepted: 19 April 2022 / Published: 26 April 2022
(This article belongs to the Special Issue Edible Plants: From Chemistry to Health Benefits)
Browse Figure
Versions Notes

Abstract

:
Cornus species are widely distributed in central and southern Europe, east Africa, southwest Asia, and America. Several species are known for edible fruits, especially Cornus mas and Cornus officinalis. These delicious fruits, characterized by their remarkable nutritional and biological values, are widely used in traditional medicine. In contrast to the other edible Cornus species, C. mas and C. officinalis are the most studied for which little information is available on the main phytochemicals and their biological activities. Fruits are characterised by several classes of secondary metabolites, such as flavonoids, phenolic acids, lignans, anthocyanins, tannins, triterpenoids, and iridoids. The available phytochemical data show that the different classes of metabolites have not been systematically studied. However, these edible species are all worthy of interest because similarities have been found. Thus, this review describes the traditional uses of Cornus species common in Europe and Asia, a detailed classification of the bioactive compounds that characterize the fruits, and their beneficial health effects. Cornus species are a rich source of phytochemicals with nutritional and functional properties that justify the growing interest in these berries, not only for applications in the food industry but also useful for their medicinal properties.

Graphical Abstract

1. Introduction

The genus Cornus L. (Cornaceae) comprises about 65 species widely distributed in central and southern Europe, east Africa, southwest Asia, and America [1]. Among the edible species of the genus, Cornus, Cornus mas L., C. officinalis Sieb. et Zucc, C. kousa Hanse, and C. controversa Hemsl. have fruits widely consumed in Europe and Asia [2].
C. mas (cornelian cherry) is native to southern Europe and southwest Asia [3]. This plant comes from the foothills of the Caucasus, and from there, it spreads over Romania, Bulgaria, Italy, Turkey, and the inland European continent [4]. Ripe (cherry red or dark) fruits are used for fresh consumption or the production of marmalade, jam, yoghurt, compote, liquor, soup with rice, syrup, juice, and wine [5].
C. sanguinea L. (European dogwood, blood twig dogwood, or common dogwood) is a species widely distributed in the temperate regions of Europe [6] and the Caucasian region. It is a small tree with leaves with a characteristic dark red colour in senescence [7]. It can be found in most vegetation types but usually in different mixed temperate broad-leaved forests dominated by oak, lime, maple, ash, elm and hornbeam. Usually, this species is cultivated for ornamental purposes for its decorative flowers and colourful leaves. Dogwood berries are a non-toxic fruit with a tart flavour that makes them unpleasant for raw consumption. They are used in jams and juices.
C. officinalis (Asiatic dogwood, Japanese cornel or cornel dogwood) is diffused in eastern Asia, mainly in China, Korea, and Japan [8]. It is a deciduous tree that grows in the warm temperate zone but presents a specific cold resistance; it can temporarily grow in a −18 °C low-temperature zone. C. officinalis red berries are edible and picked after the summer. They have been used in traditional Chinese medicine for more than 2000 years [9].
C. kousa (Korean dogwood and Japanese dogwood) is a native plant of East Asia, mainly in Korea, China, and Japan. It is a small deciduous tree, and its fruits have been traditionally used in therapeutic medicine [10]. Among Cornus species, the largest fruits are C. kousa fruits; they have a sweet flavour and are sometimes used for wine production. Like C. sanguinea, C. kousa is also cultivated as an ornamental tree because it presents a high resistance to pests and diseases [11].
C. controversa (giant dogwood) is a deciduous tree native to Japanese, China and Korean temperate forests. It grows until 15 m tall, and its ripe fruits (purplish-red or bluish-black) are smaller compared with other Cornus species [11].
After describing botanically the edible Cornus species and their use in folk medicine, our study focuses on listing and comparing the compounds belonging to the main classes of bioactive secondary metabolites, the main biological activities and the involvement of certain compounds in the effects known to date.

2. Study Design

The available information on Cornus species was collected from the following scientific databases: PubMed, Web of Science, Reaxys, SciFinder, Scopus and Google Scholar or the databases of publishers. The search terms used for this review included “Cornus”, “Cornus species”, “Cornus mas”, “Cornus sanguinea”, “Cornus officinalis”, “Cornus controversa”, “Cornus kousa”, “traditional uses”, “chemical profile”, “flavonoids”, “iridoids”, “monoterpenes”, “triterpenes”, “tannins”, “fatty acids”, “biological activity”, and “toxicity”.
The interest in Cornus species as a rich source of compounds with nutritional and biological properties is demonstrated by numerous studies in the literature.
Herein, we have covered the period from January 2017 to March 2022. However, several interesting works published before 2017 were described to comment on the reported data critically and evaluate and compare the most promising investigated bioactivities and the newly identified constituents.
To find relevant studies, works were screened based on title and abstract. Only English language papers were included in this study to confine our search. Inclusion criteria were phytochemical studies; in vitro, ex vivo, and in vivo studies; and studies with or without proposals of the mechanisms of action.

3. Traditional Uses of Cornus Fruits

Fruits, leaves, and flowers of C. mas have been traditionally used for more than 1000 years to treat several diseases, including measles, digestion problems, rickets, anaemia, hepatitis A, and pyelonephritis diseases [4,12,13,14]. In particular, all edible Cornus fruits are used in folk medicine (Table 1). C. mas and C. officinalis fruits are widely used in Europe and Asia for their applications in traditional medicine. C. mas is used in Slovakia to treat fever, digestive disorders, and inflammation, and in Iran for the treatment of malaria, diarrhoea, inflammatory bowel disease, fever, kidney stones, urinary tract infections, and cancer [4,15,16,17,18]. In Turkish folk medicine, the berries of C. mas and C. sanguinea are used as remedies for gastrointestinal disorders [19,20,21].
In Chinese traditional medicine, C. officinalis is known as a tonic to protect and nourish the kidney and liver [8]. In addition, it is accepted in the Chinese Pharmacopoeia (2010), and it is recognised as a principal and active herb in many medical prescriptions [44]. It is used alone or in combination with other herbs to ameliorate the clinical symptoms of liver and kidney disorders. In fact, the symptoms caused by kidney and liver deficiency, such as dizziness, weakness of the waist and knees, and tinnitus, were cured with C. officinalis and other plants [43]. Moreover, it is used to treat urinary disease, cough, asthmatic problems, diabetes, night sweats, frequent urination, impotence and seminal emission [48]. C. controversa is used in Korea and China as an astringent and tonic [46]. In traditional Korean medicine, C. kousa is employed to treat diarrhoea and as a haemostatic agent [47].
In conclusion, the traditional uses of these Cornus, mainly by the oral route, are very diverse. Some indications are often found: gastrointestinal disorders, throat and pulmonary infections, and kidney diseases. However, C. mas appears to be used to treat a wider range of infections.

4. The Main Chemical Constituents of Cornus Fruits

Edible fruits of Cornus contain phenolic compounds [49] such as tannins [9], anthocyanins [11,50], flavonoids [50], lignans [51], and aromatic acids, and terpenoids such as iridoids [52] as the main bioactive compounds [53]. However, currently, not all these classes of bioactive metabolites have been systematically investigated in the fruits of edible plants.
C. mas fruits have been the subject of numerous phytochemical studies, and many of its compounds are described. The fruits are rich in flavonoids, iridoids, triterpenes and fatty acids.
The literature shows that the chemical composition of the fruits of C. officinalis has also been extensively studied. Similarly, flavonoids, tannins, and iridoids are the main chemical constituents of this species. In addition, the presence of organic acids, polysaccharides, sterols, phenylpropanoids, lignans, furans and mineral substances has also been described. Early work on the fruits of C. kousa concerned the identification of triterpene glycosides [54] and lignans [55,56].
Recently, a comprehensive chemical profile of anthocyanins, flavonoids and organic acids was published [57]. Currently, only a few studies have investigated the chemical composition of other Cornus species. The identification of flavonoids was performed in C. sanguinea, and a description of the anthocyanins in C. controversa was carried out.

4.1. Flavonoids and Proanthocyanidins

Among flavonoids, flavonol glycosides are the major constituents, mainly with kaempferol or quercetin as aglycones. Quercetin 3-O-glucuronide is the major constituent in the methanol extract of C. mas fruits [50]. Other flavonols have an aglycon, such as myricetin. Flavanonols such as aromadendrin and flavanones including naringenin 3-O-methylester 7,3′-dihydroxy-5,4′-dimethoxyflavanone, and 4-acetoxy-5,2′,4′,6′-β-pentahydroxy-3-methoxychalcones are specifically found in the fruits. Among proanthocyanidins and flavonoids, catechin is predominant in the hydroalcoholic fruit extract, followed by epicatechin and procyanidin B2 [49].
The literature revealed that few studies of the chemical profile of C. sanguinea drupes have been conducted. Popović et al. [20] reported the presence of several quercetin 3-O-glycosides in the methanolic extract of the fruits. These are essentially quercetin glycosides that differ in the nature of the sugar part. Quercetin 3-O-glucuronide, 3-O-glucoside, 3-O-galactoside, 3-O-rhamnoside and 3-O-rutinoside (rutin) were found [20].
A recent study identified other heterosides, quercetin 3-O-β-D-galactopyranoside-4-O-β-D-glucopyranoside, quercetin 3,4′-di-O-β-D-glucopyranoside, myricetin 3-O-α-L-arabinopyranoside-4-O-β-D-glucopyranoside, ampelopsin 3-O-β-D-glucopyranoside and isorhamnetin 3-O-β-D-glucuronopyranoside [58].
The flavonoids reported in C. officinalis have been characterised by naringenin, kaempferol and quercetin aglycons [59]. In addition, it should be noted that quercetin and kaempferol heterosides are numerous. Epicatechin 3-O-gallate is only found in C. officinalis fruits [60].
Similar to other Cornus species, fruits of C. kousa are characterised by quercetin derivatives (quercetin 3-O-galactoside, quercetin 3-O-xyloside and quercetin 3-O-glucoside) and by kaempferol and myricetin heterosides [57,61,62]. The principal flavonoids and proanthocyanidins found in Cornus fruits are reported in Table 2.
The concentration is, in order: delphinidin 3-O-glucoside > delphinidin 3-O-rutinoside > cyanidin 3-O-glucoside [11]. In the same study, C. kousa fruits are analysed.
In this species, high amounts of cyanidin 3-O-glucoside are found, followed by cyanidin 3-O-galactoside and very small quantities of delphinidin 3-O-glucoside [11]. A recent study reported pelargonidin 3-O-galactoside in C. kousa fruits ([57]).
Among Cornus fruits, the lowest amounts of anthocyanins were found in the fruits of C. kousa. [11]. The anthocyanins isolated in Cornus fruits are reported in Table 3.

4.2. Lignans

Lignans were studied only in C. officinalis and C. kousa fruits. They were found by analysing an aqueous extract of C. officinalis and a hydroalcoholic extract of C. kousa.
Once again, a study of the C. officinalis extract revealed a very large number of compounds. A total of 18 lignans were identified from the aqueous extract; among them were frequent compounds with a dihydrodiconiferous skeleton, pinoresinol, and isolariciresinol. However, it should be noted that officinalignan A and B are unusual derivatives of neolignan glucopyranoside, which have only been identified in this species. Officinalignan B has a dihydrobenzofuran skeleton with a galloyl group attached [51]. Similar compounds, namely dihydrodehydrodiconiferyl alcohol (+)-pinoresinol, (+)-lariciresinol, threo and erythreo guaiacylglycerol-β-coniferyl aldehyde ether, (+)-pinoresinol, (-)-balanophonin and cornuskoside A, have been identified in C. kousa [56,72]. Table 4 reports the main lignans identified in Cornus fruits.

4.3. Tannins

Analysis of the literature on iridoid plants showed that tannins are scarcely or not present in the fruits. Among the Cornus edible fruits, tannins have been reported only in C. officinalis and C. mas [73].
For C. mas, the determination of tannins in fruit extracts revealed their presence in small or medium quantities, and so far, no tannins have been isolated and identified [74,75]. However, it should be noted that ellagic acid, a marker of hydrolysable ellagitannins, has been described in fruits and that hydrolysable tannins, such as cornusiins, are numerous in the stones of these fruits [49].
While so far, no data concerning identifying tannins in C. mas fruits are available, many tannins have been isolated from C. officinalis fruits. Therefore, the richness of hydrolysable tannins in C. officinalis was considered a remarkable difference compared to C. mas. The main constituents are ellagitannins and gallotannins such as 7-O-galloyl-D-sedoheptulose [9,73,76,77,78]. Among these tannins, dimers and trimers have molecular weights sometimes higher than 1000 D, such as cornusiins A−F and camptothins A−B. It should be noted that cornusiins were first found in the fruits of C. officinalis, and that recently, some of these compounds have been found in the stones.

4.4. Acids and Phenolic Acids

Twelve organic acids, namely malic, maleic, malonic, oxalic, succinic, citric, isocitric, tartaric, fumaric, quinic, shikimic, and ursolic acid, are identified in C. mas fruits [65,69,75,79,80]. Malic acid, followed by tartaric acid and citric acid, are the principal acids reported in the acidified aqueous extract of C. mas fruits collected in Bosnia and Herzegovina [65]. Fruits of C. mas collected in the Czech Republic possessed citric acid as the major organic acid [67]. Thirteen phenolic acids have also been described. Ellagic acid together with chlorogenic and gallic acids are the predominant phenolic acids found in hydroalcoholic extracts of C. mas fruits collected in Serbia [49]. Conversely, fruits from the Czech Republic reported chlorogenic acid as the principal phenolic acid. Other phenolic acids, including neochlorogenic acid, p-coumaric acid, vanillic acid, and ferulic acid, are reported in the methanol extract of C. mas fruits [81,82].
The acids described in C. officinalis are numerous. There are seventeen organic acids, including eight triterpenoids and twelve phenolic acids. Methyl gallate and gallic acid have been identified in the methanol extract of C. officinalis [83]. Other phenolic acids and acids, namely 2-O-(4-hydroxybenzoyl)-2,4,6-trihydroxyphenyl-methylacetate, p-coumaric acid, caffeic acid, ellagic acid, 3,5-dihydroxybenzoic acid, 3-hydroxy-2,4-di-amino-pentanoic acid, tartaric acid, betulinic acid, butyl malic acid, protocatechuic acid, dimethylmalate, malic, and 2-butoxybutanedioic acid, were recognised in C. officinalis fruits [64,84]. A few years later, caftaric acid monomethyl ester [60], caffeoyltartaric acid dimethyl ester [85], 3,5-dihydroxy-2-(2-methoxy-2-oxoethyl) phenyl 4-hydroxybenzoate [8], succinic acid, and citric acid were added to the chemical composition of C. officinalis fruits [86].
In C. kousa fruits, triterpenoid acids are numerous, and seven are described (arjunolic, asiatic, 19-hydroxyasiatic, betulinic, corosolic, maslinic, oleanic, pimaric, tormentic, ursolic and 2α-hydroxylursolic acid) [47,87,88]. Five different organic acids (citric, fumaric, oxalic, shikimic and malic acid) and three phenolic acids (chlorogenic, neochlorogenic and 4-caffeoylquinic acid) were also identified [57].
These metabolite classes have not yet been referenced for other edible Cornus. However, it can be noted that among these common metabolites, only ursolic, malic, citric and neochlorogenic acid have been identified in C. mas, C. officinalis and C. kousa. Table 5 reports the main acids and phenolic acids identified in Cornus fruits.

4.5. Carotenoids

Carotenoids were identified only in two species of Cornus edible fruits, C. mas and C. kousa. Ten carotenoids, namely β-carotene, β-carotene-5,6-monoxide, β-cryptoxanthin, lutein, lutein-5,6-epoxide, (9Z, 9′Z)-lutein, (13Z, 13′Z)-lutein, (all-E)-neoxanthin, (9′Z)-neoxanthin, luteoxanthin, are reported in the hydroalcoholic extract of C. mas fruits treated with hexane [93]. Six carotenoids, namely lutein, neoxanthin, violaxanthin, antheraxanthin, zeaxanthin, α-carotene, and β-carotene, are found in C. kousa fruits [57].

4.6. Iridoids

The taxonomic classification of the Cornus genus belongs to the super division Spermatophyta, division Magnoliophyta, class Magnoliopsida (dicotyledon), sub-class Rosidae, order Cornales, family Cornaceae and genus Cornus L. [1]. This classification is in accordance with iridoids as taxonomic markers of this genus [94,95]. Since Jensen et al. [94] and Bate-Smith et al. [95], it has been established that the taxonomically informative chemical compounds reported are cornin and loganin. Morroniside, whose formation was established in vivo derivation from secologanin, is only found in C. officinalis [94].
Cornel iridoid glycoside is one of the main components of C. officinalis, together with morroniside and loganin [96].
To the best of our knowledge, among the edible Cornus, the presence of iridoids in the fruits has only been investigated in the species C. mas and C. officinalis.
Table 6 shows that all identified iridoids have a C10 skeleton. In the fruits of C. mas, the taxonomic markers of the genus Cornus were identified, as well as some derivatives such as sweroside, loganic acid and cornuside, an iridoid frequently found in the genus Cornus. Loganic acid, loganin, and sweroside have been detected in the hydroalcoholic extract of fruits and juice [52,82].
In addition to the iridoids found in C. mas extract, many other iridoids are described in the fruits of C. officinalis. For example, derivatives of loganin esterified with malic acid are present [105]. Secoiridoids are numerous; in addition to those mentioned above, demethoxy-cornuside, secologanoside, secoxyloganin were identified. However, the main secoiridoid is morroniside, whose isomeric forms are in equilibrium (α and β morroniside) [105]. Probably due to the solvent’s nature, the α and β isomeric forms of morroniside ethyl and methyl were also isolated.
α,β-Morronisides are precursors of many derivatives. Glycosylation reactions between the C-7 of morronisides and glucose or fructose alcohol functions yielded twelve morroniside diglycosides (Cornusdiglycosides A−J) [114]. The alcohols of the morronisides reacted with the C-7 carbon of a second morroniside, forming dimers of methyl and ethyl morronisides (Cornuside A-J, Williamsoside D). The links between the two morronisides units are (6′-O-7″) and (2′-O-7″) [104]. Similarly, iridoid dimers of the cornuside-morroniside (Cornusdiridoid A−F) [99] and loganin-morroniside (Cornuside L-O) [51,104,105] types were also formed. The links are of the type (2′-O-7′′′), (3′-O-7′′′), (4′-O-7′′′), (6′-O-7′′′) and (6′-O-7′′′), (2′-O-7″), (4′-O-7″), respectively. Moreover, the tryptamine also reacted with morroniside, forming monoterpene indol alkaloids (MIA) in the form of 3β(R)-vincosamide, 7-epi-javaniside and javaniside [99]. In addition, unusual compounds such as logmalicides A and B [8], cornusfurosides A−D [110], and cornus phenosides A-I [111] were identified.

4.7. Other Constituents

Glucose, fructose and sucrose are present in high concentrations in the hydroalcoholic extract of C. mas fruits. Glucose is the major carbohydrate, followed by fructose and sucrose [74,115]. Contrary to what is observed in C. mas, fructose is the main sugar in C. kousa, followed by glucose. C. kousa presents a sweet taste and a higher total sugar content than other Cornus edible fruits [57]. In C. officinalis fruits, only sucrose is found [64]. C. mas fruits are rich in potassium, calcium, magnesium and sodium content. Other minerals such as phosphorus, iron, zinc, copper and manganese are present in smaller quantities. Variability was found in dependence on the collection site [74,116,117,118]. For example, fruits from the Czech Republic showed a variability in potassium (3798–3411 mg/kg), calcium (656–301 mg/kg), magnesium (290–241 mg/kg), and sodium (82–58 mg/kg) depending on the type of cultivar [116]. Fruits from cultivars of Serbia exhibited 5609–1845 mg/kg of potassium, 466–27 mg/kg of calcium, 315–40 mg/kg of sodium, and 161–10 mg/kg of magnesium [74]. Variability in mineral content was also found in the samples collected in Croatia and Greece. In the C. mas fruits collected in Croatia, the main mineral was potassium (4019 mg/kg), followed by calcium (2074 mg/kg), magnesium (288 mg/kg) and sodium (22.9 mg/kg) [118]. A different composition was reported for fruits from Greece, with potassium (1320–880 mg/kg), phosphorus (90–80 mg/kg), magnesium (50–40 mg/kg), iron (45–19 mg/kg) and calcium (30–20 mg/kg) identified as the main minerals [117]. Compared with other fruit juices (pear, plum and apple juices), the C. mas fruit juice was richer in various minerals such as potassium, calcium, sodium, iron, zinc, copper and manganese [119]. There was little difference in the mineral composition between C. mas and C. officinalis fruits. These last species did not demonstrate the presence of sodium and phosphorus in their composition [120].
The vitamins identified in the aqueous extracts of C. mas fruits are ascorbic acid, α-tocopherol, biotin, and riboflavin. Their concentration varies depending on the cultivar and climatic conditions [121]. As far as C. officinalis, only γ-tocopherol has been identified in the essential oil obtained from its fruits, and other data concerning vitamins are completely missed [122]. Regarding C. kousa, ascorbic acid, α-tocopherol and γ-tocopherol are found in its fruits [57]. In a recent study, only ascorbic acid was described in C. sanguinea [71].
Most published works do not mention the quantification of isolated metabolites or the different compounds in the extracts. The study of C. mas cultivars showed that the concentration of the latter changes, and these differences might explain the role of metabolites. For example, for fruits from C. mas cultivars, it has been shown that total phenolic content and ascorbic acid content are correlated with high biological efficiency in antioxidant activity [3].

5. Biological Properties

C. mas demonstrated antioxidant, antibacterial, antidiabetic, hypolipidemic, anti-inflammatory, anticancer, and anticoagulant properties [1]. Additionally, C. officinalis is known to have different biological properties, such as antimicrobial, antineoplastic, hypoglycaemic, antioxidant, anti-inflammatory, cardioprotective, and neuroprotective activities, and has been traditionally used to improve and protect kidney and liver functions [48]. Conversely, few studies assessed the bioactivities of C. sanguinea, C. kousa and C. controversa [123] until now. Herein, we described the most investigated properties. The main investigated biological activities are summarized in Table 7.

5.1. Antioxidant Activity

The fruits of C. mas are a good source of antioxidants [3,70,81,124,125,126,127]. Bayram and Ozturkcan [75] reviewed the antioxidant properties of different extracts, juice, liqueur and wine of C. mas. In a study by Serteser et al. [127], the hydroalcoholic extract of fruits from C. mas collected in Turkey showed an interesting inhibition against DPPH radical and H2O2 activity and a high Fe2+ chelating activity.
Another study analyzed the antioxidant capacities of the Cornus species typically found in the Mediterranean area. The hydroalcoholic extract obtained by C. mas fruits from Northern Greece showed high protection (98.6%) in the deoxyribose protein assay, along with the Hull thornless blackberry (red-black, Rubus fruticosus) (98.9%).
Raspberries and gooseberries presented a low capacity [125]. The antioxidant activity is influenced by the phytochemical content, which is influenced by different factors, including genotype, site of collection, maturity stage, climatic conditions, and extraction procedures. The methanol extract of C. mas air-dried fruits showed a lower FRAP value (83.9 μM ascorbic acid equivalent (AAE)/g, dry weight (DW)) compared with lyophilized fruits (FRAP value of 190 μM AAE/g, DW) [81,125].
During the drying process, a decomposition of bioactive compounds such as anthocyanins and ascorbic acid was observed, which is the reason for a reduced FRAP activity. Tural and Koca [70] investigated various C. mas genotypes of Turkey and reported different FRAP activity (16.21–94.43 μM AAE/g, fresh weight (FW)). In addition, the presence of pelargonidin 3-O-glucoside was the main pigment found in these fruits. Stanković et al. [128] used solvents of different polarities, such as methanol, water, ethyl acetate, petroleum ether, and acetone, to obtain different C. mas fruit extracts. The highest antioxidant activity was reported for the ethyl acetate extract with an IC50 value of 11.06 μg/mL in the DPPH test.
This activity could be associated with total phenolic content (179.05 mg gallic acid equivalent/g) and flavonoid concentration (41.49 mg rutin equivalent/g). Moreover, the DPPH radical scavenging activity of the ethyl acetate extract is similar to standard compounds (butylated hydroxyanisole (BHA; 5.39 μg/mL), rutin (9.28 μg/mL) and chlorogenic acid (11.65 μg/mL).
Serteser et al. [127] compared the antioxidant activity of the hydroalcoholic extract of C. sanguinea fruits with other plants collected in Turkey, demonstrating that C. sanguinea has the highest DPPH radical scavenging activity. A similar trend was observed with Fe2+ chelating and H2O2 inhibition activities. Moreover, this extract was more active in the H2O2 inhibition test than extracts of other plants. The methanol extract of C. sanguinea fruits collected in Iran showed an interesting antioxidant activity in the DPPH test, with an IC50 value of 94.83 μg/mL [123]. A lower DPPH radical scavenging activity was found by Stanković and Topuzović [129], who analysed different C. sanguinea fruit extracts. The acetone extract showed a high capacity to reduce DPPH radicals with an IC50 value of 247.83 μg/mL, followed by methanol extract (358.59 μg/mL), water extract (384.85 μg/mL), ethyl acetate extract (537.83 μg/mL) and petroleum ether extract (1202.85 μg/mL).
Previously, Lee et al. [130] studied the antioxidant activities of n-hexane, chloroform, ethyl acetate, ethanol, and water extracts of C. officinalis dried fruits. Antioxidant activity was investigated in a linoleic acid emulsion system by measuring the peroxide value, while radical scavenging activity was determined through the DPPH test. All extracts reported significantly higher DPPH radical scavenging activity than the positive control.
Water and ethanol extracts exhibited higher activities compared to other extracts. The same trend was observed in the linoleic acid emulsion system [130]. Additionally, in the same study, the protective effects of C. officinalis extract against apoptotic damage in H2O2-treated human umbilical vein endothelial cells (HUVECs) were assessed. Ethanol extract decreased cell death, preserving morphological normality by eliminating hydroxyl radicals.
In another study, Kim et al. [131] investigated the in vivo antioxidant effect of C. officinalis aqueous extract. In diabetic rats treated with a dose of 500 mg/kg, the activities of xanthine oxidase (XO), catalase (CAT), and glutathione-S-transferase (GST) were lower than the diabetic group. In contrast, the superoxide dismutase (SOD) activity increased by 26%. Thus, it is possible to deduce that antioxidant activity could be linked to the regulation of enzymes.
Successively, West et al. [102], investigated the antioxidant capacities of C. officinalis juice. This juice showed a promising DPPH radical scavenging activity (82.32 percent DPPH radical scavenging activity), moderate reducing power (30.71 mmol Fe2+/mL) and oxygen radical absorbance capacity (22.31 μmole Trolox equivalent/mL). Interestingly, the C. officinalis juice reducing power activity is greater than reported for other juices such as apple, pomegranate, açaí, black cherry, blueberry, cranberry, Concord grape, and orange juices [132]. The hydroalcoholic (70% ethanol) extract of C. officinalis fruits showed an interesting antioxidant activity in the DPPH test, with an IC50 value of 99.32 μg/mL. In addition, in the ABTS test, this extract demonstrated a scavenging activity of 40.7% at a 100 μg/mL concentration. Additionally, it exhibited a high ability to reduce ferric complex (241.5 mM), similar to the positive control (256.1 mM). This high antioxidant activity should be associated with phenolic compounds found in this species [133].

5.2. Antidiabetic and Anti-Obesity Activities

Diabetes mellitus is a chronic metabolic disorder of multiple aetiology. Type 2 diabetes represents over 90% of diabetes and is associated with reduced sensitivity to insulin by peripheral tissues. One therapeutic approach for treating type 2 diabetes is to reduce postprandial hyperglycemia by inhibiting carbohydrate-hydrolysing enzymes, such as α-glucosidase and α-amylase [134].
C. officinalis, whose dried and mature fruits have traditionally been used for preventing diabetes mellitus, diabetic nephropathy, chronic inflammatory diseases and liver disease, is mainly distributed in Eastern Asia, Southern and Central Europe, and Eastern North America [135]. The antidiabetic properties of C. officinalis were studied in non-insulin-dependent diabetes mellitus (NIDDM) rats by oral administration (1 once daily for 30 d). In NIDDM, the expression of GLUT4 mRNA was significantly reduced. Still, the administration of C. officinalis alcohol extract notably increased the GLUT4 mRNA and protein expression, thus increasing insulin secretion and accelerating the metabolism of glucose [136].
Treatment with C. officinalis extract (oral administration of 300 mg/kg) in streptozotocin (STZ)-induced diabetic rats for 4 weeks reduced blood glucose and triglycerides (TG), significantly alleviating polyuria, polyphagia, polydipsia and weight loss. In addition, the oral administration of C. officinalis protected against damage to diabetes-induced pancreas and kidney injury, increased the pancreas’s beta cells, and consequently increased insulin levels [137]. Previously, Yamabe et al. [138] assessed the antidiabetic properties of C. officinalis fruits in STZ-induced diabetic rats by gavage. The experimental groups that received the extract at doses of 50, 100, and 200 mg/kg body for 10 days presented a reduction in proteinuria, hyperglycemia, renal advanced glycation end-product (AGE) formation, and the expression of related proteins, such as the receptor for AGEs, nuclear factor-κB (NF-κB), transforming growth factor-β1, and Nε-(carboxymethyl)lysine [138].
Moreover, Park et al. [139] demonstrated that C. officinalis extract could reduce serum glucose levels by inhibiting the α-glucosidase enzyme. In another study, the insulin-mimetic action of C. officinalis on dexamethasone and 8-bromo-cAMP-induced phosphoenolpyruvate carboxykinase (PEPCK) expression in H4IIE cells (rat hepatoma cell) was studied. C. officinalis methanol extract showed potent insulin mimic activity on PEPCK expression, increasing the cell viability and promoting insulin secretion [140]. The therapeutic effects of C. officinalis extract were also confirmed by Gao et al. [141]. Extract was administered at doses of 100, 200, or 400 mg/kg by oral gavage to STZ-induced diabetic rats. Reduction in blood glucose, high-density lipoprotein (HDL), low-density lipoprotein (LDL), TG, urinary protein levels and water consumption was observed. At the highest doses tested (200 and 400 mg/kg), creatinine and serum albumin levels were significantly reduced. The expression of peroxisome proliferator-activated receptor-gamma (PPARγ) was improved with SOD, CAT and glutathione peroxidase (GPx) activities. Thus, decreasing oxidative stress and enhancing the PPARγ expression can improve diabetic nephropathy.
Iridoids and secoiridoids are characteristic and active constituents of C. officinalis. They have been reported to possess anti-diabetic, antioxidant and anti-inflammatory properties [114]. The iridoid glycosides cornusdiglycosides A−J, isolated from the fruits of C. officinalis, were recently assessed for their potential α-glucosidase inhibitory activity. All iridoids inhibited α-glucosidase, with IC50 values ranging from 78.9 to 162.2 μM [114]. Cornusdiglycosides A−H revealed better inhibitory activity than acarbose, used as a positive control.
Successively, six unusual cornuside-morroniside secoiridoid dimers, namely cornusdiridoid A−F, isolated from the fruits of C. officinalis, were investigated as potential a-glucosidase inhibitory agents [99]. Among the tested compounds, cornusdiridoid A−C exhibited the most promising activity with IC50 values of 243.5–267.1 μM (acarbose, 276.3 μM).
An et al. [142] obtained total saponins from C. officinalis by using ultrasonic microwave-assisted extraction. This extract, purified by a non-polar copolymer styrene type macroporous resin (HPD-300), improved the glucose and lipid metabolism of streptozotocin-induced diabetic mice and ameliorated liver and pancreas damage, inflammation as well as oxidative stress. The C. officinalis total saponin extract regulated insulin receptor-, phosphatidylinositol 3-kinase-, glucose transporter 4-, and protein kinase B-associated signaling pathways.
A literature survey also reported several studies that analysed C. mas for its potential antidiabetic activity. The hydroalcoholic extract of C. mas fruits (100 mg/kg, intraperitoneal (i.p.)) exhibited antidiabetic activity in alloxan-induced diabetic rats by reducubg serum glucose, LDL, TG, and very-low-density lipoprotein (VLDL) levels and by increasing HDL [143].
The oral administration of C. mas fruits (5, 10 and 15 g/meal) as a diet supplement for 20 days in hamsters decreased body weight and increased insulin levels [144]. Successively, Shamsi et al. [145] demonstrated that the oral administration of C. mas fruits (2 g/kg/day (d) for 4 weeks in alloxan-induced diabetic rats exhibited antidiabetic effects comparable to the positive control glibenclamide (0.6 mg/kg/d) [146].
In a clinical study, 60 patients with type 2 diabetes were randomly assigned to two groups receiving a C. mas anthocyanin-rich extract or placebo capsules (2 capsules twice daily after main food) orally along with their usual diet and physical activity. Each capsule contained 150 mg of anthocyanins isolated from the aqueous ethanol extract of C. mas fresh fruits. After 6 weeks, a significant increase in insulin levels and a decrease in haemoglobin AIc (HgbAIC) and TG levels were observed in the treated group in comparison to the placebo. These results suggested that the consumption of C. mas fruits might improve glucose intolerance in type 2 diabetic patients by increasing insulin levels and reducing the HgbAIC and TG levels [147].
Anthocyanins, of which C. mas fruits are very rich, have been shown to reduce the development of obesity through suppressed fat accumulation, significantly increasing the enzyme activity responsible for lipolysis of TG [148,149]. Jayaprakasam et al. [150] demonstrated that cyanidin and delphinidin glucosides stimulated insulin production in vitro. In contrast, Zhang et al. [151] showed that ursolic acid decreases blood glucose through insulin receptor phosphorylation and the stimulation of glucose uptake.
The consumption of lyophilized C. mas fruit powder (doses of 500 and 1000 mg/kg bw/d) reduced mice’s fasting plasma glucose levels after 12 weeks without affecting the homeostatic model assessment of insulin resistance [152].
Similar results were obtained in the study by Dzydzan et al. [153], which demonstrated that red and yellow C. mas fruit ethanol extracts (20 mg/kg intraperitoneal injection (i.p.) for 14 days) were able to reduce the fasting plasma glucose levels and increase glucose intolerance. Moreover, the hydroalcoholic (75% ethanol) extract of C. mas fruits (100 mg/kg bw/d for 3 days) decreased serum glucose, TG, LDL, and VLDL levels and HDL levels. These effects were similar to glibenclamide treatment (50 mcg/kg i.p.) (an anti-diabetic drug), while reductions in TG and VLDL by hydroalcoholic extract of C. mas fruits were greater than glibenclamide [143].
Different extracts (obtained by different extraction procedures) and constituents of C. mas, including anthocyanins, iridoids, and ursolic acid, showed anti-diabetic effects by using several in vitro and in vivo procedures. However, more studies are needed to confirm which extract or compound is more effective.

5.3. Hypolipidemic and Anti-Atherosclerotic Properties

The effects of C. mas fruits on hypercholesterolemic rabbits were evaluated [154]. The administration of C. mas fruits to rabbits (1 g/kg body weight (b.w.)/d for 60 days) decreased serum fibrinogen levels. This effect was better than the anti-fibrinogenic drug, lovastatin (10 mg/kg b.w./d for 60 days). Therefore, the consumption of C. mas fruits as a diet supplement might be beneficial to reduce the risk of cardiovascular diseases in atherosclerotic patients. Authors applied the same protocol to rabbits, with a significant decrease in LDL, malondialdehyde (MDA), TG, total cholesterol (TC), fibrinogen and atherogenic index parameter. Additionally, an increase in antioxidant activity was observed. Probably, this effect is related to the number of phenolic compounds and vitamins (ascorbic acid and tocopherol) [155].
In another study on postmenopausal women, participants were randomly separated into two groups. One group received C. mas fruit extract (300 mg) 3 times a day for 8 weeks, and another group received a placebo. After the treatment, body weight, waist circumference, BMI, LDL/HDL ratio, TC/HDL ratio, and fibrinogen decreased. Moreover, C. mas supplementation increased Apo A1 and HDL levels compared to the control group. However, although both groups’ fasting plasma glucose levels decreased, no change in leptin levels, serum insulin, insulin resistance index and insulin sensitivity were appreciated. This work revealed that daily consumption of C. mas fruits might help decrease blood sugar parameters and lower the risk of cardiovascular diseases. Successively, Sozanski et al. [68] investigated the protective effect of C. mas fruits against atherosclerosis and hypertriglyceridemia in a rabbit model. Fruits (100 mg/kg b.w.) or simvastatin (5 mg/kg b.w.) were administered orally for 60 days. A significant increase in liver peroxisome proliferator-activated receptor α (PPARα) protein expression and a significant decrease in serum triglyceride levels (44%), pro-inflammatory cytokines, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) was demonstrated. Based on these results, C. mas fruits showed protective effects against diet-induced hypertriglyceridemia and atherosclerosis across increased PPARα protein expression by regulating oxidative stress and inflammation [68]. It was demonstrated that the activation of PPARα leads to the increased tissue-specific expression of crucial genes involved in fatty acid uptake and β-oxidation [156].
PPARα decreases triglycerides by increasing free fatty acid β-oxidation, hepatic lipoprotein lipase expression, and expression of apolipoprotein V, and by decreasing expression of apolipoprotein CIII. Furthermore, PPARα activation regulates HDL metabolism by stimulating hepatic expression of apoA-I and apoA-II, thus raising HDL production in the liver, promoting HDL-mediated cholesterol efflux from macrophages, and inhibiting cellular cholesteryl ester formation activity, as well as contributing to an enhanced efflux of free cholesterol to extracellular receptors. PPARα activation may indirectly influence atherosclerosis development through the effects of glucose and lipid homeostasis on adipose tissue, liver, and skeletal muscle. In addition, PPARα activation may directly affect inflammation by modification of NF-κB and activator protein-1 (AP-1).
By regulating oxidative stress and inflammation, it is possible to conclude that both loganin and cornuside are responsible for the hypolipidemic activity of the extract. In fact, loganin showed anti-inflammatory capacities in various disease models, including acute pancreatitis and Parkinson’s disease ([157,158]. The iridoid was able to inhibit inflammatory cytokines and deactivation of the NF-κB signalling pathway. Moreover, it was demonstrated that the administration of loganin could improve memory-enhancing long-term memory in hippocampal tissues [159].
Cornuside was demonstrated to dilate vascular smooth muscle through endothelium-dependent nitric oxide signalling [160] and showed anti-inflammatory activity in the lipopolysaccharide (LPS)-induced inflammation model via the inhibition of NF-κB activity [161]. Previously, Kang et al. [162] observed that the addition of cornuside to human umbilical vein endothelial cell cultures reduced the mRNA expression of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) and diminished TNFα-induced NF-κB activation. In a carrageenan-induced mouse paw edema model, loganic acid exhibited a strong anti-inflammatory activity [163].
Loganic acid and cornuside were shown to increase PPAR-α levels by reducing atherosclerotic plaque formation in cardiovascular diseases [164].
The hypocortisol and hypolipidemic effects of C. mas fruits (5–15 g/daily) were studied in a hamster model [165]. At the highest dose, a decrease in cholesterol (108.3 mg/mL) and LDL (21 mg/mL) level were observed, as well as increased HDL (54 mg/mL) and TG (191.7 mg/mL) levels. The hamsters treated with C. mas fruits also showed a decrease in cortisol levels (28.8 ng/mL) compared with control (45.8 ng/mL).
As demonstrated by the different described works, the consumption of C. mas fruits may benefit lipid disorders. A recent systematic review and meta-analysis of the effects of cornelian fruit supplementation on the blood lipid profile of animal studies revealed that the supplementation considerably reduced the levels of LDL, TG, and cholesterol and increased HDL levels compared to the control group [166].
Consequently, these findings suggest that C. mas fruits supplementation may have lipid-modifying properties, which might be because these fruits are a good source of polyphenols and anthocyanins. However, long-term clinical studies and well-designed human studies should be necessary to further evaluate the impacts of cornelian consumption on various health outcomes.
C. officinalis was evaluated for its hypolipidemic activity [167]. The extract was able to reduce serum and hepatic total cholesterol levels and lipid peroxidation at an oral dose of 50, 100, or 200 mg/kg for 10 days. Moreover, expression of the sterol regulatory element-binding protein (SREBP)-2 was reduced, whereas expression of the PPARα protein was enhanced. These results suggest using C. officinalis to prevent cardiovascular disease by controlling cholesterol levels and the expression of proteins related to lipid metabolism.

5.4. Neuroprotective Effects

A literature survey revealed the presence of several studies that have proposed C. officinalis and C. mas as potential therapeutic agents to treat neurodegenerative diseases, including Alzheimer’s disease (AD).
By using APP/PS1/tau triple transgenic (3 × Tg) mice as a model of AD, Yang et al. [168] revealed that cornel iridoid glycoside, the dominant active constituent of C. officinalis, could ameliorate learning and memory impairments of 3 × Tg mice by down-regulating the expression of Aβ and full-length amyloid precursor protein, as well as decreasing the hyper-phosphorylation of tau protein. These results were confirmed by Ma et al. [169], which demonstrated that this iridoid could reduce the hyperphosphorylation and aggregation of tau protein in the amygdala, prevent neuronal loss, and suppress the hyperactivity phenotype of AD. Tian et al. [170] used immobilization stress that induced depressive-like and anxiety-like behaviours and hippocampal neuronal damage in rodents to investigate the protective properties of C. officinalis extract on nerve injury. Results showed that C. officinalis successfully alleviated oxidative stress, decreased immobility time in the forced swim test, increased serotonin levels and significantly reduced corticosterone and β-endorphin levels. Iridoid glycosides of C. officinalis could reduce corticosterone-induced PC12 cell damage [97]. Corticosterone-induced PC12 injury is considered an in vitro experimental model for depression, and PC12 cells have typical neuron characteristics and are widely used to study neurological diseases [171]. In another study [172], a decoction of C. officinalis fruits exhibited protective effects against neurodegenerative diseases. Treatment with an extract (60 µg/mL) stimulated neurite extension similarly to a prominent neurotrophic factor, increasing the percentage of adrenal gland pheochromocytoma (PC12) cells bearing neurites.
The administration of freeze-dried C. mas fruits protected the brain tissue by reducing the amount of free radicals generated in the brain tissue. These effects were demonstrated in three types of diet: control, fructose and high-fat diets in rats with increased activity of catalase (CAT) and paraoxonase (PON) in brain tissue and decreased levels of the protein carbonyl group and thiol groups in brain tissue as well as in plasma [173]. PON is responsible for the anti-atherogenic effects of HDL in blood, possesses anti-inflammatory properties and prevents the oxidation of lipoproteins [174]. Phenolic compounds and ascorbic acid in C. mas fruits probably play a significant role in increasing PON-1 levels [175].
Some Cornus constituents have been studied as potential neuroprotective agents. Among them, morroniside can promote both the proliferation and differentiation of endogenous neural stem cells and the migration of neural stem cells in vivo. Nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) are important bioactive molecules in the nervous system for their role in developing the central nervous system while maintaining the normal functions of the mature central and peripheral nervous system neurons. Morroniside enhanced the function of NGF and the expression of BNDF [176,177]. The effects of morroniside on the expression of the Wnt7a gene and adenomatous polyposis coli (APC) were assessed in rats with focal cerebral ischemia-reperfusion injury [178]. The Wnt is a pathway that can regulate cell proliferation and differentiation during the growth and development of humans and animals, particularly in brain plasticity. Wnt7a is an important ligand that can regulate the acceleration of cell growth and differentiation and inhibit glial regeneration. Conversely, the APC gene inhibits the Wnt signaling pathway. Morroniside promoted the expression of Wnt7a and inhibited the expression of APC.

5.5. Antimicrobial Activity

The n-hexane extract of C. mas fruits showed significant antibacterial activity against Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli at the tested dose of 10 μL/disc [179]. Methanol and ethanol extracts of C. mas fruits revealed antibacterial activity against E. coli, S. aureus, and Pseudomonas aeruginosa, but demonstrated no antifungal properties against Candida albicans and Aspergillus fumigates. However, Streptococcus pyogenes and Trichophyton mentagrophytes resulted in resistance [180].
The antimicrobial effects of a hydroalcoholic extract of C. mas fruits were successively investigated against 13 species of bacteria and yeast [49]. The Gram-positive strains Listeria monocytogenes, Bacillus cereus, S. aureus, and Sarcina lutea and the Gram-negative strains Proteus vulgaris, Shigella sonnei, and Salmonella enteritidis were the most sensitive. A positive correlation between antimicrobial activity and total phenol content was found. The scientifically proven antibacterial activity justified using C. mas fruits in traditional medicine to treat gastrointestinal disorders and diarrhoea, skin diseases, and urinary infections [181,182,183,184]. The antimicrobial effect of apple juice supplemented with C. officinalis fruits against E. coli O157:H7 was evaluated [185]. Results showed that adding C. officinalis fruits inactivates E. coli O157:H7 in apple juice. The most promising results were observed at 21 °C, while at 7 °C, only a reduction of 2.3 log cfu/mL was observed. Therefore, C. officinalis fruit extract can be used with temperature and storage time conditions to inactivate E. coli O157:H7 in apple juice.

5.6. Other Bioactivities

The hydroalcoholic extract of C. mas fruits (5 μg/mL) exhibited cytotoxic activity against breast adenocarcinoma (MCF-7), prostate adenocarcinoma (PC-3), ovarian cancer (SKOV-3), and non-small cell lung cancer (A549) cells [186]. The mean growth inhibition was 81.8, 81.9, 81.6, and 79.3% in the SKOV3, MCF-7, PC-3, and A549 cell lines, respectively. Previously, Chang et al. [187] demonstrated that a decoction of C. officinalis fruits at the dose of 100 µg/mL was able to inhibit hepatocellular carcinoma cell (58.1%) and leukemic cell (51.2%) growth.
The hepato-protective effect of C. mas was also proven. Fruits were administered at 200 and 500 mg/kg b.w., ameliorating the levels of aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase (ALP) and reducing the oxidative stress and elevated hepatic MDA content in CCl4-induced hepatotoxicity in rats by Alavian et al. [188]. Another research group demonstrated that the hydroalcoholic extract of C. mas fruits exerted renal-protective effects by improving renal lesions, antioxidant enzymes, lipid peroxidation-induced MDA levels, and other biochemical parameters, including creatinine, uric acid and serum urea levels [189].
The oral administration of a hydroalcoholic extract of C. mas fruits (50, 200 and 400 mg/kg b.w./d) exhibited a significant reduction in the platelet distribution width (PDW) [190], a specific marker of platelet activation [191]. This marker is activated when blood coagulation is necessary and consequently decreases with platelets’ inactivation.
In rats, CCl4 injection can decrease antioxidant enzymes and increase creatinine kinase, lactate dehydrogenase and MDA, with consequent damage to different tissues, including the heart. Treatments with the hydroalcoholic extract of C. mas fruits at a dose of 300 and 700 mg/kg b.w./d for 16 days in CCl4-induced intoxicated rats showed cardioprotective effects. These effects were linked to attenuating myocardial lipid peroxidation levels and recovering the enzymatic defense system by increasing the levels of SOD, CAT, and GPx and modulating cardiac tissue’s bioenergetics state [192].
Loganin, one of the most common iridoid glycosides isolated from Cornus species, was recently investigated on angiotensin II-induced cardiac hypertrophy [193]. Angiotensin II is a significant component of the renin-angiotensin system and plays an important role in triggering hypertension and myocardial hypertrophy. Loganin was demonstrated to inhibit angiotensin II–provoked cardiac hypertrophy and cardiac damage in the H9C2 cell line in mice. It showed cardio-protective effects through a decrease in pro-inflammatory cytokine secretion, the suppression of the phosphorylation of critical proteins including STAT3, JAK2, IκBα, and p65, and the attenuation of cardiac fibrosis. These promising results are supported by previous works that have shown the ability of loganin to suppress inflammatory responses by downregulating the activation of JAK2/STAT3 and NF-κB signaling pathways and decreasing the production of inflammatory cytokines [194,195,196,197].
The administration of loganic acid, isolated from C. mas fruits, at a dose of 0.7% aqueous solution containing 0.15% sodium hyaluronate significantly reduced (25%) conjunctivitis-induced intraocular pressure (IOP) of the eye in a rabbit model [82].
This activity is of certain interest as a possible treatment for diabetic retinopathy. The decrease in IOP was probably ascribed to reducing nitric oxide [198,199]. A similar effect was also observed in a glaucoma model. Glaucoma is characterised by high levels of nitric oxide that decrease after loganic acid treatment [198,199].
Osteoporosis is a chronic illness closely linked with the aging processes. Based on traditional medicine and modern findings in the pathogenesis and treatment of osteoporosis, a variety of natural products present in preparations of this plant play a beneficial role.
C. officinalis significantly inhibits receptor activator of nuclear factor-κB ligand (RANKL)-mediated osteoclast differentiation in a dose-dependent manner and RANKL-induced phosphorylation of p38 and c-JUN N-terminal kinase. In addition, the protein expression of c-Fos and nuclear factor of activated T cells cytoplasmic 1 (NFATc1) is suppressed due to the RANKL-induced degradation of I-κB kinase [200]. The effects of the main constituents of C. officinalis fruits, such as morroniside, on osteoarthritis in human chondrocytes were studied. Morroniside supported the survival of chondrocytes with articular cartilage thickness, increasing the levels of type II collagen and improving the level of proteoglycans in the cartilage matrix [201].
Studies conducted on C. officinalis revealed a reduction in the incidence of infections or allergic illnesses by stimulating the innate immune system. In particular, Kim, Kim, and Lee [202] evaluated the therapeutic effects of C. officinalis in a mouse model of allergic asthma. This model demonstrated reduced production of Th2 cytokines (IL-5), eotaxin, and specific immunoglobulin E (IgE) and reduced eosinophil infiltration. C. officinalis fruits improve non-specific immunity, specific humoral immunity, and cellular immunity, as confirmed in a previous study conducted by Du et al. [203] in immuno-depressed mice.
Table
Table 7. The main biological activities described for Cornus species.
Table 7. The main biological activities described for Cornus species.
Extracts or CompoundsCountryEffectsReference
C. mas
Antioxidant activity
Hydroalcoholic extract of dried fruitsTurkeyAntioxidant activity (DPPH assay: IC50 of 1.078 mg/mL) and high inhibition against H2O2 activity (74.35%)[127]
Hydroalcoholic extract of dried fruitsGreeceAntioxidant activity in FRAP test (83.9 μM AAE/g of DW) and deoxyribose test (98.6%)[125]
Methanol extract of fresh fruitsIranAntioxidant activity in FRAP assay (190 μM AAE/g of DW) and DPPH assay (3.95–9.67 mg/mL)[81]
Methanol extract of fresh fruitsTurkeyAntioxidant activity tested with FRAP test (16.21–94.43 μM AAE/g of FW) and DPPH test (IC50 value of 0.29–0.69 mg/mL)[70]
Methanol, aqueous, ethyl acetate, petroleum ether and acetone extracts of fresh fruitsSerbiaAntioxidant activity in DPPH assay (IC50 of 251,86, 518.47, 11.06, 107.99, and 285.98 μg/mL for methanol, aqueous, ethyl acetate, acetone, petroleum ether extracts, respectively)[128]
Antidiabetic and anti-obesity activities
Hydroalcoholic extract of fresh fruits Antidiabetic activity in alloxan-induced diabetic rats by reductions in serum glucose, LDL, TG, and VLDL levels and increase in HDL[143]
Fresh fruitsIranDecrease in body weight and increase in insulin levels[144,145,146]
Hydroalcoholic extract of fresh fruitIranIncrease in insulin level, decrease in HgbAIC and TG levels[147]
Aqueous extract of fresh fruitsSlovakiaReduction in plasma glucose levels[152]
Ethanol extract Reduction in plasma glucose levels and increase in glucose intolerance[153]
Cyanidin and delphinidin glucosides Stimulation of insulin production[150]
Ursolic acid Decrease in blood glucose and stimulation of glucose uptake[151]
Hypolipidemic and anti-atherosclerotic properties
Dried fruitsIranDecrease in serum fibrinogen levels, LDL, MDA, TG, TC, fibrinogen and atherogenic index parameter[154,155]
Fruit extractIranDecrease in body weight, waist circumference, BMI, LDL/HDL ratio, TC/HDL ratio, and fibrinogen, and increase in Apo A1 and HDL levels[204]
Fresh fruitsPolandProtective effects against diet-induced hypertriglyceridemia and atherosclerosis through an increase in PPARα protein expression and a significant decrease in serum triglyceride levels, pro-inflammatory cytokines, IL-6, and TNF-α[68]
Fresh fruitsIranDecrease in cholesterol, LDL, and cortisol levels; increase in HDL and TG levels[165]
Loganin Inhibition of inflammatory cytokines and deactivation of NF-κB signalling pathway[157,158]
Cornuside Dilated vascular smooth muscle through endothelium-dependent nitric oxide signalling[160]
Cornuside Anti-inflammatory activity via the inhibition of NF-κB activity[161]
Loganic acid and cornuside Increase in PPAR-α levels with reduced atherosclerotic plaque formation in cardiovascular diseases[164]
Neuroprotective effects
Fresh fruitsPolandProtection of the brain tissue by reducing the free radical content by increased activity of CAT and PON[173]
Antimicrobial activity
n-Hexane extract of fresh fruitsRussianAntibacterial activity against S. aureus and E. coli[179]
Methanol and ethanol extracts of fresh fruitsPolandAntibacterial activity against S. aureus, E. coli P. aeruginosa[180]
Hydroalcoholic extract of fresh fruitsSerbiaAntibacterial activity against L. monocytogenes, B. cereus, S. aureus, S. lutea, P. vulgaris, S. sonnei, and S. enteritidis [49]
Cytotoxic activity
Hydroalcoholic extract of dried fruitsIranCytotoxic activity against MCF-7, PC-3, SKOV-3 and A549 cells[186]
Hepatoprotective effect
Hydroalcoholic extract of dried fruitsIranAmelioration of AST, ALT and ALP levels [188]
Renal protective activity
Hydroalcoholic extract of dried fruitsIranRenal protective effects via improving renal lesions, antioxidant enzymes, creatinine, uric acid and serum urea levels [189]
Cardioprotective and antiplatelet activities
Hydroalcoholic extract of dried fruitsIranCardioprotective effects through a reduction in PDW, attenuating myocardial lipid peroxidation level and recovering enzymatic defence system by increasing the levels of SOD, CAT, GPx, and modulating the bioenergetics state of cardiac tissue[190,192]
Loganin Inhibition of angiotensin II. Cardioprotective effects through a decrease in pro-inflammatory cytokine secretion, suppression of phosphorylation of critical proteins including STAT3, JAK2, IκBα, and p65, and attenuation of cardiac fibrosis[193,194,195,196,197]
Ophthalmic activity
Loganic acid Reduction in nitric oxide with consequent decrease in IOP of the eye, ameliorating glaucoma [82,198,199]
C. sanguinea
Antioxidant activityHydroalcoholic extract of dried fruitsTurkeyAntioxidant activity in DPPH assay (IC50 of 1.205 mg/mL) and high inhibition against H2O2 activity (69.03%), while in Fe2+ chelating assay showed chelating activity of 51.24% [127]
Acidic methanol extract of dried fruitsIranAntioxidant activity in DPPH assay (IC50 of 94.83 μg/mL) [123]
Aqueous, methanol, acetone,
ethyl acetate and petroleum ether extracts of fresh fruits		SerbiaAntioxidant activity in DPPH assay (IC50 of 358.59, 384.45, 537.83, 247.83, and 1202.85 μg/mL for methanol, aqueous, ethyl acetate, acetone, petroleum ether extracts, respectively)[129]
C. officinalis
Antioxidant activity
Hexane, chloroform, ethylacetate,
ethanol, and aqueous extracts of dried fruits		KoreaAntioxidant activity in DPPH and β-carotene bleaching tests. Protection by ethanol extract of HUVECs from H2O2-initiated cell death[130]
Aqueous extract of fresh fruitsKoreaIn diabetic rats, the activities of XO, CAT, and GST were lower than diabetic group[131]
JuiceTurkeyDPPH radicals scavenging activity, reducing power and oxygen radical absorbance capacity (22.31 μmole trolox equivalent/mL) [102]
Hydroalcoholic extract of fresh fruitsKoreaAntioxidant activity in DPPH test (IC50 of 99.32 μg/mL) and in ABTS test (40.7%), reduction in ferric complex (241.5 mM)[133]
Antidiabetic and anti-obesity activities
Alcoholic extract of fruitsChinaIncrease in GLUT4 mRNA and protein expression with an increase in insulin production and accelerated glucose metabolism[136]
Fresh fruitsJapanReduction in proteinuria, hyperglycaemia, renal AGE formation, and the expression of related proteins, such as the receptor for AGEs, NF-κB, transforming growth factor-β1, and Nε-(carboxymethyl)lysine[138]
Methanol extract of fruits Increase in cell viability through insulin mimicked activity of PEPCK expression [140]
Hydroalcoholic extract of fresh fruitsChinaDecrease in blood glucose, HDL, LDL, TG, creatinine, and serum albumin levels[141]
Cornusdiglycosides A−J α-Glucosidase inhibition with IC50 values in the range 78.9–162.2 mM[114]
Cornusiridoid A−F α-Glucosidase inhibition[99]
Total saponin extract Amelioration of liver and pancreas damage, regulation of insulin receptor, phosphatidylinositol 3-kinase, glucose transporter 4, and protein kinase B-associated signalling pathways[142]
Hypolipidemic and anti-atherosclerotic properties
Fresh fruits Reduction in serum and hepatic TC levels and SREBP-2. Increase in PPAR-α levels[167]
Neuroprotective effects
Aqueous extract of dried fruitsSouth KoreaAlleviation of oxidative stress, decrease in immobility time in the forced swim test, an increase in serotonin levels and reduction in corticosterone and β-endorphin levels[170]
Decoction of fresh fruitsChinaProtective effects against degenerative disease through stimulation of the neurite extension, increasing the percentage of PC12[172]
Cornel iridoid glycoside Amelioration of learning and memory impairment by down-regulating the expression of Aβ and full-length amyloid precursor protein, as well as decreasing the hyperphosphorylation of tau protein[168,169]
Morroniside Enhanced NGF function and BDNF expression. Promotion of the expression of Wnt7a and inhibition of the APC expression [176,177,178]
Antimicrobial activity
Decoction extract of fresh fruitsChinaAntibacterial activity against E.coli O157:H7[185]
Cytotoxic activity
Decoction extract of fresh fruitsChinaInhibited hepatocellular carcinoma cell and leukemic cell growth[187]
Cardioprotective activity
Loganin Cardioprotective effects through a decrease in pro-inflammatory cytokine secretion, the suppression of the phosphorylation of critical proteins including STAT3, JAK2, IκBα, and p65, and the attenuation of cardiac fibrosis[193,194,195,196,197]
Antiosteoporosis activity
Extract fruitsKoreaInhibited receptor activator of nuclear factor-κB ligand (RANKL)-mediated osteoclast differentiation and RANKL-induced phosphorylation of p38 and c-JUN N-terminal kinase. Suppression of the protein expression of c-Fos and NFATc1 [200]
Morroniside Increase in type II collagen levels and improvement of proteoglycan levels in cartilage matrix[201]
Immunomodulatory activity
Aqueous extract of fresh fruitsKoreaReduction in the incidence of infections or allergic illnesses through the stimulation of the innate immune system; in particular, decreased production of IL-5, eotaxin, and IgE[202]
Hydroalcoholic extract of dried fruitsChinaImprovement of the non-specific immunity, specific humoral immunity and specific cellular immunity[203]

6. Toxicity

C. mas has been analysed for its potential toxicity [102,189,205]. West et al. [102] investigated the acute toxicity of C. mas in both animal and human models. The authors found that 5 mL/kg bw of C. mas supplementation in rats for 14 days showed no adverse effects. The average lethal dose (LD50) value was <5200 mg/kg. In a human study, it was demonstrated that 100 g/day for 6 weeks of fresh C. mas fruit consumption did not show any toxicity [205]. Previously, Es Haghi et al. [189] showed that doses of a water extract of C. mas fruits in the range 100–1650 mg/kg for 2 weeks in mice showed no toxicity (LD50 value of 1270 mg/kg). Toxicity studies have shown C. mas consumption is safe and has no side effects; however, high doses and long-term toxicity evaluations are required.

7. Conclusions

Since ancient times, fruits from the Cornus genus have been used in traditional medicine for their beneficial health properties. Some species are edible, particularly the European C. mas and C. sanguinea. C. officinalis, C. kousa and C. controversa are the edible species diffused in the Asiatic continent.
C. mas and C. officinalis are extensively studied plants with a high biological value, which is mainly connected to their polyphenols and iridoid content.
In particular, C. mas fruits are well-known as traditional components of jams, liquors, and other fruit-based products and are a rich source of bioactive molecules. Significant amounts of anthocyanins, flavonoids, and iridoids were identified in the fruits. These phytochemicals are linked with remarkable antioxidant, anti-inflammatory, and cancer properties. Additionally, C. officinalis exhibits a broad range of pharmacological activities, including anti-inflammatory, antioxidant, antiaging, cardioprotective, neuroprotective, and antibacterial effects. As described in our review, iridoids, flavonoids, terpenoids, polysaccharides, organic acids, and other compounds have been isolated and identified from C. officinalis fruits. This interest has recently prompted researchers to investigate also interspecific hybrids of C. mas × C. officinalis [206]. These hybrids are characterized by more iridoids than C. mas and more anthocyanins than C. officinalis.
Few phytochemical studies are present for other edible Cornus species. According to this review, the fruits of these Cornus species are rich in bioactive compounds, such as flavonoids, iridoids, anthocyanins, carotenoids, and other secondary metabolites; thus, their use might represent some benefits to human health.
Fruit extracts could effectively counter the onset of various illnesses linked to diabetes, obesity, and kidney and gastrointestinal disorders. However, exhaustive future studies of C. sanguinea and C. controversa fruits’ biological properties and chemical composition are still required. In addition, pharmacokinetic and pharmacodynamic studies on C. mas and C. officinalis fruits and their derived bioactive metabolites are necessary to confirm their effectiveness for human use. Moreover, toxicity studies on phytocomplex and single bioactive compounds are necessary to ensure the safety of these uses.

Author Contributions

Conceptualization, M.C.T., R.T. and B.D.; investigation, M.C.T., B.D. and R.T., writing—original draft preparation, M.C.T., R.T., C.C., B.D.; writing—review and editing, M.C.T., B.D., M.R.L., C.C., M.B., V.S., L.T., A.-C.M.-O., J.X., R.T.; supervision, B.D. and R.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Dinda, B.; Kyriakopoulos, A.M.; Dinda, S.; Zoumpourlis, V.; Thomaidis, N.S.; Velegraki, A.; Dinda, M. Cornus mas L. (cornelian cherry), an important European and Asian traditional food and medicine: Ethnomedicine, phytochemistry and pharmacology for its commercial utilization in drug industry. J. Ethnopharmacol. 2016, 193, 670–690. [Google Scholar] [CrossRef] [PubMed]
  2. Seeram, N.P.; Schutzki, R.; Chandra, A.; Nair, M.G. Characterization, quantification and bioactivities of anthocyanins in Cornus species. J. Agric. Food Chem. 2002, 50, 2519–2523. [Google Scholar] [CrossRef] [PubMed]
  3. Rop, O.; Mlcek, J.; Kramarova, D.; Jurikova, T. Selected cultivars of cornelian cherry (Cornus mas L.) as a new food source of human nutrition. Afr. J. Biotechnol. 2010, 9, 1205–1210. [Google Scholar] [CrossRef] [Green Version]
  4. Asadov, S.; Ibrahimov, Z.A.; Sadigova, S.A. Zoghal (Cornus mas L.); Azerbaijan Academy of Science, Institute of Botany: Baku, Azerbaijan, 1990; p. 72. (In Turkish)
  5. Brindza, P.; Brindza, J.; Toth, D.; Klimenko, S.V.; Grigorieva, O. Slovakian cornelian cherry (Cornus mas L.): Potential for cultivation. Acta Hortic. 2007, 760, 433–438. [Google Scholar] [CrossRef]
  6. Krüsi, B.O.; Debussche, M. The fate of flowers and fruits of Cornus sanguinea L. in three contrasting Mediterranean habitats. Oecologia 1988, 78, 592–599. [Google Scholar] [CrossRef]
  7. Kollmann, J.; Grubb, P.J. Biological flora of Central Europe: Cornus sanguinea L. Flora 2001, 196, 161–179. [Google Scholar] [CrossRef]
  8. Ma, W.; Wang, K.J.; Cheng, C.S.; Yan, G.Q.; Lu, W.L.; Ge, J.F.; Cheng, Y.X.; Li, N. Bioactive compounds from Cornus officinalis fruits and their effects on diabetic nephropathy. J. Ethnopharmacol. 2014, 153, 840–845. [Google Scholar] [CrossRef]
  9. Dong, Y.; Feng, Z.-L.; Chen, H.-B.; Wang, F.-S.; Lu, J.-H. Corni Fructus: A review of chemical constituents and pharmacological activities. Chin. Med. 2018, 13, 34–54. [Google Scholar] [CrossRef] [Green Version]
  10. Khan, M.I.; Shin, J.H.; Shin, T.S.; Kim, M.Y.; Cho, N.J.; Kim, J.D. Anthocyanins from Cornus kousa ethanolic extract attenuate obesity in association with anti-angiogenic activities in 3T3- L1 cells by down-regulating adipogeneses and lipogenesis. PLoS ONE 2018, 13, e0208556. [Google Scholar] [CrossRef]
  11. Vareed, S.K.; Reddy, M.K.; Schutyki, R.E.; Nair, M.G. Anthocyanins in Cornus alternifolia, Cornus controversa, Cornus kousa and Cornus florida fruits with health benefits. Life Sci. 2006, 78, 777–784. [Google Scholar] [CrossRef]
  12. Damirov, I.A.; Prilipko, L.I.; Shukurov, D.Z.; Kerimov, J.B. Medicinal Plants of Azerbaijan; Baku: Maarif, Azerbaijan, 1983. (In Russian) [Google Scholar]
  13. Lewis, W.H.; Elvin-Lewis, M.P.F. Medical Botany: Plants Affecting Human Health, 2nd ed.; John Wiley and Sons: New York, NY, USA, 1977. [Google Scholar]
  14. Tzitzin, N.B.; Anichkov, C.V.; Itzkov, N.Y. An Atlas of Medicinal Plants of the USSR; Gosudarstvenoye Medizinskoye Izdatelstvo: Moscow, Russia, 1963. (In Russian) [Google Scholar]
  15. Bertova, L. Cornales dienotvare. In Flora Slovenska, 1st ed.; Bertova, L., Ed.; VEDA: Bratislava, Slovakia, 1984; Volume 4, pp. 389–415. [Google Scholar]
  16. Celik, S.; Bakirci, I.; Sat, I.G. Physicochemical and organoleptic properties of yogurt with cornelian cherry paste. Int. J. Food Prop. 2006, 9, 401–408. [Google Scholar] [CrossRef] [Green Version]
  17. Zargari, A. Medicinal Plants, 6th ed.; Tehran University Publication: Tehran, Iran, 1996; Volume 3, p. 538. (In Persian) [Google Scholar]
  18. Guler, B.; Kumustekin, G.; Egurlu, E. Contribution to the traditional uses of medicinal plants of Turgutlu (Manisa-Turkey). J. Ethnopharmacol. 2015, 176, 102–108. [Google Scholar] [CrossRef] [PubMed]
  19. Bulut, G. Folk medicinal plants of Silivri (Istanbul, Turkey). Marmara Pharm. J. 2011, 1, 25–29. [Google Scholar] [CrossRef]
  20. Popović, Z.; Bajić-Ljubičić, J.; Matić, R.; Bojović, S. First evidence and quantification of quercetin derivatives in dogberries (Cornus sanguinea L.). Turkish J. Biochem. 2017, 42, 513–518. [Google Scholar] [CrossRef]
  21. Zlatkovic, B.K.; Bogosavljevic, S.S.; Radivojevic, A.R.; Pavlovic, M.A. Traditional use of the native medicinal plant source of Mt. Rtanj (Eastern Serbia): Ethnobotanical evaluation and comparison. J. Ethnopharmacol. 2014, 151, 704–713. [Google Scholar] [CrossRef] [PubMed]
  22. Pieroni, A.; Cianfaglione, K.; Nedelcheva, A.; Hajdari, A.; Mustafa, B.; Quave, C.L. Resilience at the border: Traditional botanical knowledge among Macedonians and Albanians living in Gollobordo, Eastern Albania. J. Ethnobiol. Ethnomed. 2014, 10, 31. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Tita, I.; Mogosanu, G.D.; Tita, M.G. Ethnobotanical inventory of medicinal plants from the South-West of Romania. Farmacia 2009, 57, 141–156. [Google Scholar]
  24. Reich, L. Cornelian cherry: From the shores of Ancient Greece. Arnoldia 1996, 56, 2–7. [Google Scholar]
  25. Chevallier, A. The Encyclopedia of Medicinal Plants; Darling Kindersley Ltd.: London, UK, 1996. [Google Scholar]
  26. Polat, R.; Cakilcioglu, U.; Satil, F. Traditional uses of medicinal plants in Solhan (Bingol-Turkey). J. Ethnopharmacol. 2013, 148, 951–963. [Google Scholar] [CrossRef]
  27. Genc, G.E.; Ozhatay, N. An ethnobotanical study in Catalca (European part of Istanbul) II. Turkish J. Pharm. Sci. 2006, 3, 73–89. [Google Scholar]
  28. Altundag, E.; Ozturk, M. Ethnomedicinal studies on the plant resources of east Anatolia, Turkey. Procedia-Soc. Behav. Sci. 2011, 19, 756–777. [Google Scholar] [CrossRef] [Green Version]
  29. Egea, T.; Signorini, M.A.; Bruschi, P.; Rivera, D.; Obon, C.; Alcaraz, F.; Palazou, J.A. Spirits and liqueurs in European traditional medicine: Their history and ethnobotany in Tuscany and Bologna (Italy). J. Ethnopharmacol. 2015, 175, 241–255. [Google Scholar] [CrossRef] [PubMed]
  30. Jarić, S.; Popović, Z.; Mačukanović-Jocić, M.; Djurdjević, L.; Mijatović, M.; Karadžić, B.; Mitrović, M.; Pavlović, P. An ethnobotanical study on the usage of wild medicinal herbs from Kopaonik Mountains (Central Serbia). J. Ethnopharmacol. 2007, 111, 160–175. [Google Scholar] [CrossRef]
  31. Savikin, K.; Zdunic, G.; Menkovic, N.; Zivkovic, J.; Cujic, N.; Terescenko, M.; Bijovic, D. Ethnobotanical study on traditional use of medicinal plants in South- Western Serbia, Zlatibor district. J. Ethnopharmacol. 2013, 146, 803–810. [Google Scholar] [CrossRef] [PubMed]
  32. Miraldi, E.; Ferri, S.; Mostaghimi, V. Botanical drugs and preparations in the traditional medicine of West Azerbaijan (Iran). J. Ethnopharmacol. 2001, 75, 77–87. [Google Scholar] [CrossRef]
  33. Saric-Kundalic, B.; Dobes, C.; Klatte-Asselmeyer, V.; Saukel, J. Ethnobotanical survey of traditionally used plants in human therapy of east, north and north-east Bosnia and Herzegovina. J. Ethnopharmacol. 2011, 133, 1051–1076. [Google Scholar] [CrossRef] [PubMed]
  34. Baytop, T. Medicinal and Poisonous Plants of Turkey; Istanbul University Publications: Istanbul, Turkey, 1963. [Google Scholar]
  35. McGuffin, M.; Hobbs, C.; Upton, R.; Goldberg, A. The American Herbal Products Association’s Botanical Safety Handbook; CRC Press: Boca Raton, FL, USA, 1997; p. 37. [Google Scholar]
  36. Hsu, P.C.; Tsai, Y.; Lai, J.; Wu, C.; Lin, S.; Huang, C. Integrating traditional Chinese medicine healthcare in to diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: A population-based case control study. J. Ethnopharmacol. 2014, 156, 358–364. [Google Scholar] [CrossRef]
  37. Rexhepi, B.; Mustafa, B.; Hajdari, A.; Rushidi-Rexhepi, J.; Quave, C.L.; Pieroni, A. Traditional medicinal plant knowledge among Albanians, Macedonians and Gorani in the Sharr Mountains (Republic of Macedonia). Genet. Resour. Crop Evol. 2013, 60, 2055–2080. [Google Scholar] [CrossRef]
  38. Mustafa, B.; Hajdari, A.; Krasniqi, F.; Hoxha, E.; Ademi, H.; Quave, C.L.; Pieroni, A. Medical ethnobotany of the Albanian Alps in Kosovo. J. Ethnobiol. Ethnomed. 2012, 8, 6. [Google Scholar] [CrossRef] [Green Version]
  39. Jia, W.; Gao, W.; Tang, L. Antidiabetic herbal drugs officially approved in China. Phytother. Res. 2003, 17, 1127–1134. [Google Scholar] [CrossRef]
  40. Di Novella, R.; Di Novella, N.; De Martino, L.; Mancini, E.; De Feo, V. Traditional plant use in the National Park of Cilento and Vallo di Diano, Campania, Southern Italy. J. Ethnopharmacol. 2013, 145, 328–342. [Google Scholar] [CrossRef] [PubMed]
  41. Sokolov, S.; Zamotayev, I. Directory of Medicinal Plants; Medicina: Moscow, Russian, 1985. (In Russian) [Google Scholar]
  42. Polinicencu, C.F.; Popescu, H.; Nistor, C. Vegetal extracts for cosmetic use: 1. extracts from fruits of Cornus mas. Preparation and characterization. Clujul Med. 1980, 53, 160–163. [Google Scholar]
  43. Song, X.Y.; Chen, Q.; Qi, X.Y. Effect of Liuwei Dihuang pill on erythrocyte aldose reductase activity in early diabetic nephropathy patients. Chin. J. Integr. Med. 2004, 24, 1087–1090. [Google Scholar]
  44. National Pharmacopoeia Committee. Pharmacopoeia of People Republic of China; Chemical Industry Press: Beijing, China, 2010.
  45. Wang, Y.; Wang, C. Three cases of clinical application of Guchong Decoction. Chin. J. Tradit. Chin. Med. Pharm. 2010, 25, 2041–2043. [Google Scholar]
  46. Jang, H.M.; Yeon, H.B.; Soo, K.M.; Ho, L.D.; Jung, K.S.; Seup, R.J.; Soon, L.K. Chemical components from the stem bark of Cornus controversa HEMSL. Saengyak Hakhoechi 1998, 29, 225–230. [Google Scholar]
  47. Lee, D.Y.; Lakoon, J.; Park, J.H.; Yoo, K.H.; Chung, I.S.; Baek, N.I. Cytotoxic triterpenoids from Cornus kousa fruits. Chem. Nat. Compd. 2007, 46, 142–145. [Google Scholar] [CrossRef]
  48. Huang, J.; Zhang, Y.; Dong, L.; Gao, Q.; Yin, L.; Quan, H.; Chen, R.; Fu, X.; Lin, D. Ethnopharmacology, phytochemistry, and pharmacology of Cornus officinalis Sieb. et Zucc. J. Ethnopharmacol. 2018, 213, 280–301. [Google Scholar] [CrossRef]
  49. Milenkovic-Andjelkovic, A.S.; Andjelkovic, M.Z.; Radovanovic, A.N.; Radovanovic, B.C.; Nikolic, V. Phenol composition, DPPH radical scavenging and antimicrobial activity of Cornelian cherry (Cornus mas) fruit and leaf extracts. Hemijska industrija 2015, 69, 331–337. [Google Scholar] [CrossRef] [Green Version]
  50. Pawlowska, A.M.; Camangi, F.; Braca, A. Quali-quantitative analysis of flavonoids of Cornus mas L. (Cornaceae) fruits. Food Chem. 2010, 119, 1257–1261. [Google Scholar] [CrossRef] [Green Version]
  51. Peng, Z.; Wang, Y.; He, J.; Zhang, J.; Pan, X.; Ye, X.; Zhang, W.; Xu, J. Chemical constituents and their antioxidant and anti-inflammatory activities from edible Cornus officinalis fruits. Eur. Food Res. Technol. 2022, 248, 1003–1010. [Google Scholar] [CrossRef]
  52. Deng, S.; West, B.J.; Jensen, C.J. UPLC-TOF-MS characterization and identification of bioactive iridoids in Cornus mas fruit. J. Anal. Methods Chem. 2013, 2013, 710972. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Krivoruchko, E.V. Carboxylic acids from Cornus mas. Chem. Nat. Compd. 2014, 50, 112–113. [Google Scholar] [CrossRef]
  54. Lakoon-Jung; Lee, D.Y.; Cho, J.G.; Kim, S.Y.; Baek, N.I. Isolation of Triterpene Glycosides from the Fruit of Cornus kousa. J. Korean Soc. Appl. Biol. Chem. 2009, 52, 45–49. [Google Scholar] [CrossRef]
  55. Lee, D.Y.; Song, M.C.; Yoo, K.H.; Bang, M.H.; Chung, I.S.; Kim, S.H.; Kim, D.K.; Kwon, B.M.; Jeong, T.S.; Park, M.H.; et al. Lignans from the Fruits of Comus kousa Burg. and Their Cytotoxic Effects on Human Cancer Cell Lines. Arch. Pharm. Res. 2007, 30, 402–407. [Google Scholar] [CrossRef]
  56. Lee, D.Y.; Yoo, K.H.; Chung, I.S.; Kim, J.Y.; Chung, D.K.; Kim, D.K.; Kim, S.H.; Baek, N.I. A new lignan glycoside from the fruits of Cornus kousa Burg. Arch. Pharm. Res. 2008, 31, 830–833. [Google Scholar] [CrossRef]
  57. Schmitzer, V.; Sircelj, H.; Stampar, F.; Slatnar, A. Physico-chemical characterization of Cornus kousa Burg. fruit: Determining optimal maturity for fresh consumption. J. Sci. Food Agric. 2021, 101, 778–785. [Google Scholar] [CrossRef]
  58. Iannuzzi, A.M.; Giacomelli, C.; De Leo, M.; Russo, L.; Camangi, F.; De Tommasi, N.; Braca, A.; Martini, C.; Trincavelli, M.L. Cornus sanguinea fruits: A source of antioxidant and antisenescence compounds acting on aged human dermal and gingival fibroblasts. Planta Med. 2021, 87, 879–891. [Google Scholar] [CrossRef]
  59. Zhang, Y.E.; Liu, E.H.; Li, H.J.; Ping, L.I. Chemical constituents from the fruit of Cornus officinalis. Chin. J. Nat. Med. 2010, 7, 365–367. [Google Scholar] [CrossRef]
  60. Liang, J.R. The Studies on Chemical Constituents and Bioactivities of Cornus officinalis; Northwestern University: Evanston, IL, USA, 2014. [Google Scholar]
  61. Vareed, S.K.; Schutzki, R.E.; Nair, M.G. Lipid peroxidation, cyclooxygenase enzyme and tumor cell proliferation inhibitory compounds in Cornus kousa fruits. Phytomedicine 2007, 14, 706–709. [Google Scholar] [CrossRef]
  62. Lee, D.Y.; Lyu, H.N.; Kwak, H.Y.; Jung, L.K.; Lee, Y.H.; Kim, D.K.; Chung, I.S.; Kim, S.H.; Baek, N.I. Isolation of flavonoids from the fruits of Cornus kousa Burg. J. Appl. Biol. Chem. 2007, 50, 144–147. [Google Scholar]
  63. Rudrapaul, P.; Kyriakopoulos, A.M.; De, U.C.; Zoumpourlis, V.; Dinda, B. New flavonoids from the fruits of Cornus mas, Cornaceae. Phytochem. Lett. 2015, 11, 292–295. [Google Scholar] [CrossRef]
  64. Chen, C.S. Chemical Constituents from the Fruit of Cornus officinalis; Anhui University: Hefei, China, 2011. [Google Scholar]
  65. Drkenda, P.; Spahic, A.; Begic-Akagic, A.; Gasi, F.; Vranac, A.; Hudina, M.; Blanke, M. Pomological characteristics of some autochthonous genotypes of cornelian cherry (Cornus mas L.) in Bosnia and Herzegovina. Erwerbs-Obstbau 2014, 56, 59–66. [Google Scholar] [CrossRef]
  66. Antolak, H.; Czyzowska, A.; Sakač, M.; Mišan, A.; Đuragić, O.; Kregiel, D. Phenolic compounds contained in little-known wild fruits as antiadhesive agents against the beverage-spoiling bacteria asaia spp. Molecules 2017, 22, 1256. [Google Scholar] [CrossRef] [PubMed]
  67. Sochor, J.; Jurikova, T.; Ercisli, S.; Mlcek, J.; Baron, M.; Balla, S.; Yilmaz, S.O.; Necas, T. Characterization of cornelian cherry (Cornus mas L.) genotypes-genetic resources for food production in Czech Republic. Genetika 2014, 46, 915–924. [Google Scholar] [CrossRef]
  68. Sozański, T.; Kucharska, A.Z.; Szumny, A.; Magdalan, J.; Bielska, K.; Merwid-Ląd, A.; Woźniak, A.; Dzimira, S.; Piórecki, N.; Trocha, M. The protective effect of the Cornus mas fruits (cornelian cherry) on hypertriglyceridemia and atherosclerosis through PPARα activation in hypercholesterolemic rabbits. Phytomedicine 2014, 21, 1774–1784. [Google Scholar] [CrossRef] [PubMed]
  69. Jayaprakasam, B.; Olson, L.K.; Schutzki, R.E.; Tai, M.H.; Nair, M.G. Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in cornelian cherry (Cornus mas). J. Agric. Food Chem. 2006, 54, 243–248. [Google Scholar] [CrossRef]
  70. Tural, S.; Koca, I. Physicochemical and antioxidant properties of cornelian cherry fruits (Cornus mas L.) grown in Turkey. Sci. Hortic. 2008, 116, 362–366. [Google Scholar] [CrossRef]
  71. David, L.; Moldovan, B.; Baldea, I.; Olteanu, D.; Bolfa, P.; Clichici, S.; Filip, G.A. Modulatory effects of Cornus sanguinea L. mediated green synthesized silver nanoparticles on oxidative stress, COX-2/NOS2 and NFkB/pNFkB expressions in experimental inflammation in Wistar rats. Mater. Sci. Eng. C. Mater. Biol. Appl. 2020, 110, 110709. [Google Scholar] [CrossRef]
  72. Lee, D.Y.; Lee, M.H.; Jung, T.S.; Kwon, B.M.; Baek, B.-M.; Rho, Y.-D. Triterpenoid and lignan from the fruits of Cornus kousa inhibit the activities of PRL-3 and LDL-Oxidation. J. Korean Soc. Appl. Biol. Chem 2010, 53, 97–100. [Google Scholar] [CrossRef]
  73. Czerwińska, M.E.; Melzig, M.F. Cornus mas and Cornus officinalis-analogies and differences of two medicinal plants traditionally used. Front. Pharmacol. 2018, 9, 894. [Google Scholar] [CrossRef]
  74. Bijelić, S.M.; Gološin, B.R.; Ninić Todorović, J.I.; Cerović, S.B.; Popović, B.M. Physicochemical Fruit Characteristics of Cornelian Cherry (Cornus mas L.) Genotypes from Serbia. HortScience 2011, 46, 849–853. [Google Scholar] [CrossRef] [Green Version]
  75. Bayram, H.M.; Ozturkcan, S.A. Bioactive components and biological properties of cornelian cherry (Cornus mas L.): A comprehensive review. J. Funct. Foods 2020, 75, 104252. [Google Scholar] [CrossRef]
  76. Hatano, T.; Ogawa, N.; Kira, R.; Yasuhara, T.; Okuda, T. Tannins of cornaceous plants. I. Cornusiins A, B and C, dimeric monomeric and trimeric hydrolyzable tannins from Cornus officinalis, and orientation of valoneoyl group in related tannins. Chem. Pharm. Bull. 1989, 37, 2083–2090. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Hatano, T.; Ogawa, N.; Kira, R.; Yasuhara, T.; Okuda, T. Tannins of cornaceous plants. II. Cornusiins D, E and F, new dimeric and trimeric hydrolyzable Tannins from Cornus officinalis. Chem. Pharm. Bull. 1989, 37, 2665–2669. [Google Scholar] [CrossRef] [Green Version]
  78. Przybylska, D.; Kucharska, A.Z.; Cybulska, I.; Sozański, T.; Piórecki, N.; Fecka, I. Cornus mas L. stones: A valuable by-product as an ellagitannin source with high antioxidant potential. Molecules 2020, 25, 4646. [Google Scholar] [CrossRef]
  79. Ognjanov, V.; Cerovic, S.; Ninic- Todorovic, J.; Jacimovic, V.; Golocin, B.; Bijelic, S.; Vracevic, B. Selection and utilization of table cornelian cherry (Cornus mas L.). Acta Hortic. 2009, 814, 121–123. [Google Scholar] [CrossRef]
  80. Hassanpour, H.; Hamidoghli, Y.; Samizadeh, H. Some fruit characteristics of Iranian cornelian cherries (Cornus mas L.). Not. Bot. Horti Agrobot. Cluj-Napoca 2012, 40, 247–252. [Google Scholar] [CrossRef] [Green Version]
  81. Behrangi, N.; Ghafoori, H.; Farahmand, Z.; Khani, E.M.; Sanati, M.H. Comparison among cornelian cherry and Prunus cerasus according to phenolic content and antioxidant capacity by three various methods of extraction. Food Nutr. Sci. 2015, 6, 1166–1173. [Google Scholar] [CrossRef] [Green Version]
  82. Szumny, D.; Sozański, T.; Kucharska, A.Z.; Dziewiszek, W.; Piórecki, N.; Magdalan, J.; Chlebda-Sieragowska, E.; Kupczynski, R.; Szeląg, A.; Szumny, A. Application of cornelian cherry iridoid-polyphenolic fraction and loganic acid to reduce intraocular pressure. Evid.-Based Complement. Altern. Med. 2015, 2015, 939402. [Google Scholar] [CrossRef]
  83. Shang, S.; Liu, Y.; Xiao, X.; Sun, Z.; Zhang, J.; Tian, S.; Jiang, X. Antioxidant properties of extracts from the stone of Cornus officinalis. Linchan Huaxue Yu Gongye 1990, 10, 217–225. [Google Scholar]
  84. Lin, M.H.; Liu, H.K.; Huang, W.J.; Huang, C.C.; Wu, T.H.; Hsu, F.L. Evaluation of the potential hypoglycemic and Beta-cell protective constituents isolated from Corni fructus to tackle insulin-dependent diabetes mellitus. J. Agric. Food Chem. 2011, 59, 7743–7751. [Google Scholar] [CrossRef] [PubMed]
  85. Park, J.Y.; Han, A.R.; Kil, Y.S.; Kang, U.; Kim, S.H.; Nam, S.J.; Seo, E.K. A new secoiridoid glycoside from the fruits of Cornus officinalis (Cornaceae). Nat. Prod. Res. 2016, 30, 1504–1510. [Google Scholar] [CrossRef] [PubMed]
  86. Zhang, Q.C.; Zhao, Y.; Bian, H.M. Anti-thrombotic effect of a novel formula from Corni fructus with malic acid, succinic acid and citric acid. Phytother. Res. 2014, 28, 722–727. [Google Scholar] [CrossRef] [PubMed]
  87. Yoo, K.H.; Park, J.H.; Lee, D.Y.; Hwang-Bo, J.; Baek, N.I.; Chung, I.S. Corosolic acid exhibits anti-angiogenic and anti-lymphangiogenic effects on in vitro endothelial cells and on an in vivo ct-26 colon carcinoma animal model. Phytother Res. 2015, 29, 714–723. [Google Scholar] [CrossRef]
  88. Cheon, S.Y.; Jin, B.R.; Kim, H.J.; An, H.J. Oleanolic acid ameliorates benign prostatic hyperplasia by regulating pcna-dependent cell cycle progression in vivo and in vitro. J. Nat. Prod. 2020, 83, 1183–1189. [Google Scholar] [CrossRef]
  89. Han, S.Y.; Pan, Y.; Yang, G.M.; Cai, B.C. Research on components of Cornus officinalis extracted by supercritical carbon dioxide. Zhongguo Zhong Yao Za Zhi 2003, 28, 1148–1150. [Google Scholar]
  90. He, K.; Song, S.; Zou, Z.; Feng, M.; Wang, D.; Wang, Y.; Li, X.; Ye, X. The hypoglycemic and synergistic effect of loganin, morroniside, and ursolic acid isolated from the fruits of Cornus officinalis. Phytother. Res. 2016, 30, 283–291. [Google Scholar] [CrossRef]
  91. Popović, Z.; Matić, R.; Bajić-Ljubičić, J.; Tešević, V.; Bojović, S. Geographic variability of selected phenolic compounds in fresh berries of two Cornus species. Trees 2018, 32, 203–214. [Google Scholar] [CrossRef]
  92. Thu, N.T.; The Hung, N.; Thuy An, N.T.; Vinh, L.B.; Binh, B.T.; Thu, N.T.B.; Khoi, N.M.; Ha, D.T. Four new phenolic compounds from the fruit of Cornus officinalis (Cornaceae) and their anti-inflammatory activity in RAW 264.7 cells. Nat. Prod. Res. 2021, 16, 1–7. [Google Scholar] [CrossRef]
  93. Horvath, G.; Turcsi, E.; Molnar, P.; Szabo, L.G.; Deli, J. Isolation and identification of carotenoids in the fruit of cornelian cherry (Cornus mas L.). Planta Med. 2007, 73, 286–288. [Google Scholar] [CrossRef]
  94. Jensen, S.R.; Kjaer, A.; Nielsen, B.J. The genus Comus: Non-flavonoid glucosides as taxonomic markers. Biochem. Syst. Ecol. 1975, 3, 75–78. [Google Scholar] [CrossRef]
  95. Bate-Smith, E.; Ferguson, I.; Hutson, K.; Jensen, S.; Nielsen, B.; Swain, T. Phytochemical interrelationships in the Cornaceae. Biochem. Syst. Ecol. 1975, 3, 79–89. [Google Scholar] [CrossRef]
  96. Ma, D.; Li, Y.; Zhu, Y.; Wei, W.; Zhang, L.; Li, Y.; Li, L.; Zhang, L. Cornel iridoid glycoside ameliorated alzheimer’s disease-like pathologies and necroptosis through RIPK1/MLKL pathway in young and aged samp8 mice. Evid Based Complement Alternat Med. 2021, 2021, 9920962. [Google Scholar] [CrossRef] [PubMed]
  97. Ji, L.; Wang, X.; Li, J.-j.; Zhong, X.-j.; Zhang, B.; Juan, J.; Shang, X.-Y. New Iridoid Derivatives from the Fruits of Cornus officinalis and Their Neuroprotective Activities. Molecules 2019, 24, 625. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  98. Lee, A.Y.; Kim, H.S.; Jo, J.E.; Kang, B.K.; Moon, B.C.; Chun, J.M.; Ji, Y.; Kim, H.K. Optimization of extraction condition for major iridoid components in fruit of corni (Cornus officinalis) by UPLC-PDA using response surface methodology. Food Sci. Biotechnol. 2012, 21, 1023–1029. [Google Scholar]
  99. Peng, Z.C.; He, J.; Pan, X.G.; Zhang, J.; Wang, Y.M.; Ye, X.S.; Xu, J.K. Secoiridoid dimers and their biogenetic precursors from the fruits of Cornus officinalis with potential therapeutic effects on type 2 diabetes. Bioorg Chem. 2021, 117, 105399. [Google Scholar] [CrossRef]
  100. Lee, J.H.; Austin, J.R.; Burdette, J.E.; Murphy, B.T. Secoiridoids from dogwood (Cornus officinalis) potentiate progesterone signaling. J. Nat. Prod. 2021, 84, 2612–2616. [Google Scholar] [CrossRef]
  101. Cai, H.; Cao, G.; Cai, B. Rapid simultaneous identification and determination of the multiple compounds in crude Fructus Corni and its processed products by HPLC-MS/MS with multiple reaction monitoring mode. Pharm. Biol. 2013, 51, 273–278. [Google Scholar] [CrossRef] [Green Version]
  102. West, B.J.; Deng, S.; Jensen, C.J.; Palu, A.K.; Berrio, L.F. Antioxidant, toxicity and iridoid tests of processed cornelian cherry fruits. Int. J. Food Sci. 2012, 47, 1392–1397. [Google Scholar] [CrossRef]
  103. Cao, G.; Zhang, C.; Zhang, Y.; Cong, X.; Cai, H.; Cai, B. Screening and identification of potential active components in crude Fructus Corni using solid-phase extraction and LC-LTQ-linear ion trap mass spectrometry. Pharm. Biol. 2012, 50, 278–283. [Google Scholar] [CrossRef]
  104. Ye, X.S.; He, J.; Cheng, Y.C.; Zhang, L.; Qiao, H.Y.; Pan, X.G.; Zhang, J.; Liu, S.N.; Zhang, W.K.; Xu, J.K. Cornusides A-O, bioactive iridoid glucoside dimers from the fruit of Cornus officinalis. J. Nat. Prod. 2017, 80, 3103–3111. [Google Scholar] [CrossRef] [PubMed]
  105. Xie, X.Y.; Wang, R.; Shi, Y.P. Chemical constituents from the fruits of Cornus officinalis. Biochem. Syst. Ecol. 2012, 45, 120–123. [Google Scholar] [CrossRef]
  106. Endo, T.; Taguchi, H. Study on the constituents of Cornus officinalis Sieb. et Zucc. Yakugaku Zasshi 1973, 93, 30–32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  107. Cao, G.; Zhang, Y.; Feng, J.; Cai, H.; Zhang, C.; Ding, M.; Cong, X.; Cai, B. A rapid and sensitive assay for determining the main components in processed Fructus Corni by UPLC-Q-TOF-MS. Chromatographia 2011, 73, 135–141. [Google Scholar] [CrossRef]
  108. Liu, Z.; Zhu, Z.Y.; Zhang, H.; Tan, G.G.; Chen, X.F.; Chai, Y.F. Qualitative and quantitative analysis of Fructus Corni using ultrasound assisted microwave extraction and high performance liquid chromatography coupled with diode array UV detection and time-of-flight mass spectrometry. J. Pharm. Biomed. Anal. 2011, 55, 557–562. [Google Scholar] [CrossRef]
  109. Wang, Y.; Li, Z.; Chen, L.; Xu, X. Antiviral compounds and one new iridoid glycoside from Cornus officinalis. Prog. Nat. Sci. Mater. Int. 2006, 16, 142–146. [Google Scholar] [CrossRef]
  110. He, J.; Ye, X.S.; Wang, X.X.; Yang, Y.N.; Zhang, P.C.; Ma, B.Z.; Zhang, W.K.; Xu, J.K. Four new iridoid glucosides containing the furan ring from the fruit of Cornus officinalis. Fitoterapia 2017, 120, 136–141. [Google Scholar] [CrossRef]
  111. Wang, X.; Liu, C.H.; Li, J.J.; Zhang, B.; Ji, L.L.; Shang, X.Y. Iridoid glycosides from the fruits of Cornus officinalis. J. Asian Nat. Prod. Res. 2018, 20, 934–942. [Google Scholar] [CrossRef]
  112. Wang, X.; Zhong, X.J.; Zhou, N.; Ji, L.L.; Li, J.J.; Cai, N.; Wang, Q.B.; Lin, P.C.; Shang, X.Y. Secoiridoid glycosides from the fruits of Cornus officinalis. Nat. Prod. Res. 2020, 36, 1–7. [Google Scholar] [CrossRef]
  113. He, J.; Xu, Y.; Xu, J.K.; Ye, X.S.; Zhang, X.X.; Zhang, W.K. Cornusglucosides A and B, two new iridoid glucosides from the fruit of Cornus officinalis. Chem. Biodivers. 2019, 16, E1900421. [Google Scholar] [CrossRef]
  114. Ye, X.S.; He, J.; Xu, J.K.; He, X.L.; Xia, C.Y.; Yan, Y.; Lian, W.W.; Zhang, W.K. Undescribed morroniside-like secoiridoid diglycosides with α-glucosidase inhibitory activity from Corni Fructus. Phytochemistry 2020, 171, 112232. [Google Scholar] [CrossRef] [PubMed]
  115. Perova, I.B.; Zhogova, A.A.; Poliakova, A.V.; Eller, K.I.; Ramenskaia, G.V.; Samylina, I.A. Biologically active substances of cornelian cherry fruits (Cornus mas L.). Vopr. Pitan. 2014, 83, 86–94. [Google Scholar] [PubMed]
  116. Dokoupil, L.; Reznicek, V. Production and use of the cornelian cherry Cornus mas L. Acta Univ. Agric. Silvic. Mendel. Brun. 2012, 60, 49–57. [Google Scholar] [CrossRef] [Green Version]
  117. Sotiropoulos, T.; Petridis, A.; Koutinas, N.; Therios, I. ‘Ntoulia-1′ and ‘Ntoulia-2′ cornelian cherries (Cornus mas L.). HortScience 2011, 46, 955–957. [Google Scholar] [CrossRef] [Green Version]
  118. Juranovic-Cindric, I.; Zeiner, M.; Krpetic, M.; Stingeder, G. ICP-AES determination of minor and major elements in cornelian cherry (Cornus mas L.) after microwave assisted digestion. Microchem. J. 2012, 105, 72–76. [Google Scholar] [CrossRef]
  119. Krosniak, M.; Gastol, M.; Szalkowski, M.; Zagrodzki, P.; Derwisz, M. Cornelian cherry (Cornus mas L.) juices as a source of minerals in human diet. J. Toxicol. Environ. Health Part A 2010, 73, 1155–1158. [Google Scholar] [CrossRef]
  120. Wang, L.L.; Zhang, T.; Chen, S.Q.; Shang, C.L. Study on the correlation between the quality of Cornus officinalis and the contents of the inorganic elements in the planting soil. Zhong Yao Cai 2011, 34, 1167–1172. [Google Scholar]
  121. Zargari, A. Medicinal Plants, Part, B; Tehran University Press: Tehran, Iran, 1997; pp. 643–645. [Google Scholar]
  122. Li, G.Y.; Yao, Y.X.; Ding, X. Studies on chemistry component and the biological activity of petroleum ether extraction from pre-and post-processed of Cornus officinalis. Zhong Yao Cai 2010, 33, 192–195. [Google Scholar]
  123. Hozoori, Z.; Pashna, Z.; Yousfbeyk, F.; Amin, G. Evaluation of antioxidant activities of methanolic extract of Cornus sanguinea subsp. australis fruits. Res. Pharm. Sci. 2012, 7, S790. [Google Scholar]
  124. Demir, F.; Kalyoncu, I.H. Some nutritional, pomological and physical properties of cornelian cherry (Cornus mas L.). J. Food Eng. 2003, 60, 335–341. [Google Scholar] [CrossRef]
  125. Pantelidis, G.E.; Vasilakakis, M.; Manganaris, G.A.; Diamantidis, G. Antioxidant capacity, phenol, anthocyanin and ascorbic acid contents in raspberries, blackberries, red currants, gooseberries and Cornelian cherries. Food Chem. 2007, 102, 777–783. [Google Scholar] [CrossRef]
  126. Popović, B.M.; Stajner, D.; Slavko, K.; Sandra, B. Antioxidant capacity of cornelian cherry (Cornus mas L.) comparison between permanganate reducing antioxidant capacity and other antioxidant methods. Food Chem. 2012, 134, 734–741. [Google Scholar] [CrossRef] [PubMed]
  127. Serteser, A.; Kargioglu, M.; Gok, V.; Bagci, Y.; Musa Ozcan, M.; Arslan, D. Antioxidant properties of some plants growing wild in Turkey. Grasas Y Aceites 2009, 60, 147–154. [Google Scholar] [CrossRef] [Green Version]
  128. Stanković, M.S.; Zia-Ul-Haq, M.; Bojovic, B.M.; Topuzovic, M.D. Total phenolic, flavonoid content and antioxidant power of leaf, flower and fruits from cornelian cherry. Bulg. J. Agric. Sci. 2014, 20, 358–363. [Google Scholar]
  129. Stanković, M.S.; Topuzović, M.D. In vitro antioxidant activity of extracts from leaves and fruits of common dogwood (Cornus sanguinea L.). Acta Bot. Gall. 2012, 159, 79–83. [Google Scholar] [CrossRef]
  130. Lee, S.O.; Kim, S.Y.; Han, S.M.; Kim, H.M.; Ham, S.S.; Kang, I.J. Corni fructus scavengers hydroxyl radicals and decreases oxidative stress in endothelial cells. J. Med. Food 2006, 9, 594–598. [Google Scholar] [CrossRef]
  131. Kim, H.J.; Kim, B.H.; Kim, Y.C. Antioxidative action of Corni fructus aqueous extract on kidneys of diabetic mice. Toxicol. Res. 2011, 27, 37–41. [Google Scholar] [CrossRef]
  132. Seeram, N.P.; Aviram, M.; Zhang, Y.; Henning, S.M.; Feng, L.; Dreher, M.; Heber, D. Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J. Agric. Food Chem. 2008, 56, 1415–1422. [Google Scholar] [CrossRef]
  133. Hwang, K.A.; Hwang, Y.J.; Song, J. Antioxidant activities and oxidative stress inhibitory effects of ethanol extracts from Cornus officinalis on raw 264.7 cells. BMC Complement. Altern. Med. 2016, 16, 1962016. [Google Scholar] [CrossRef] [Green Version]
  134. Tundis, R.; Loizzo, M.R.; Statti, G.A.; Menichini, F. Inhibitory effects on the digestive enzyme -amylase of three Salsola species (Chenopodiaceae) in vitro. Pharmazie 2007, 62, 473–475. [Google Scholar]
  135. Gao, X.; Liu, Y.; An, Z.; Ni, J. Active components and pharmacological effects of Cornus officinalis: Literature review. Front. Pharmacol. 2021, 12, 633447. [Google Scholar] [CrossRef] [PubMed]
  136. Qian, D.S.; Zhu, Y.F.; Zhu, Q. Effect of alcohol extract of Cornus officinalis Sieb. Et Zucc on GLUT4 expression in skeletal muscle in type 2 (non-insulin-dependent) diabetic mellitus rats. Zhongguo Zhong Yao Za Zhi 2001, 26, 859–862. [Google Scholar] [PubMed]
  137. Han, Y.; Jung, H.W.; Park, Y.K. Selective therapeutic effect of Cornus officinalis fruits on the damage of different organs in STZ-induced diabetic rats. Am. J. Chin. Med. 2014, 42, 1169–1182. [Google Scholar] [CrossRef]
  138. Yamabe, N.; Kang, K.S.; Goto, E.; Tanaka, T.; Yokozawa, T. Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-productmediated renal injury in Streptozotocin-treated diabetic rats. Biol. Pharm. Bull. 2007, 30, 520–526. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  139. Park, C.H.; Noh, J.S.; Tanaka, T.; Uebaba, K.; Cho, E.J.; Yokozawa, T. The effects of Corni Fructus extract and its fractions against α-glucosidase inhibitory activities in vitro and sucrose tolerance in normal rats. Am. J. Chin. Med. 2011, 39, 367–380. [Google Scholar] [CrossRef]
  140. Chen, C.C.; Hsu, C.Y.; Chen, C.Y.; Liu, H.K. Fructus Corni suppresses hepatic gluconeogenesis related gene transcription, enhances glucose responsiveness of pancreatic beta-cells, and prevents toxin induced beta-cell death. J. Ethnopharmacol. 2008, 117, 483–490. [Google Scholar] [CrossRef] [PubMed]
  141. Gao, D.; Li, Q.; Gao, Z.; Wang, L. Antidiabetic effects of Corni Fructus extract in streptozotocin-induced diabetic rats. Yonsei Med. J. 2012, 53, 691–700. [Google Scholar] [CrossRef] [Green Version]
  142. An, S.; Niu, D.; Wang, T.; Han, B.; He, C.; Yang, X.; Sun, H.; Zhao, K.; Kang, J.; Xue, X. Total saponins isolated from Corni Fructus via ultrasonic microwave-assisted extraction attenuate diabetes in mice. Foods 2021, 10, 670. [Google Scholar] [CrossRef]
  143. Mirbadalzadeh, R.; Shirdel, Z. Antihyperglycemic and antihyperlipidemic effects of Cornus mas extract in diabetic rats compared with glibenclamide. Elixir Hormo. Signal. 2012, 47, 8969–8972. [Google Scholar]
  144. Rasoulian, H.; Shahryar, H.A.; Abbaspour, R.; Lotfi, H. Effects of dietary inclusion of cornelian cherry (Cornus mas L.) fruit on body weight, insulin level and glycemic status of hamsters. Pak. J. Biol. Sci. 2012, 15, 547–550. [Google Scholar] [CrossRef] [Green Version]
  145. Shamsi, F.; Asgary, S.; Rafieian, M.; Kazemi, S.; Adelnia, A. Effects of Cornus mas L. on blood glucose, insulin and histopathology of pancreas in alloxan-induced diabetic rats. J. Isfahan Med. Sch. 2011, 29, 929–938. [Google Scholar]
  146. Asgary, S.; Rafieian-kopaei, M.; Shamsi, F.; Najafi, S.; Sahebkar, A. Biochemical and histopathological study on the anti- hyperglycemic and anti- hyperlipidemic effects of cornelian cherry (Cornus mas L.) in alloxan-induced diabetic rats. J. Complement. Integr. Med. 2014, 11, 63–69. [Google Scholar] [CrossRef]
  147. Soltani, R.; Gorji, A.; Asgary, S.; Sarrafzadegan, N.; Siavash, M. Evaluation of the effects of Cornus mas L. fruit extract on glycemic control and insulin level in type 2 diabetic adult patients: A randomized double-blind placebo-controlled clinical trial. Evid. Based Complement. Alternat. Med. 2015, 2015, 740954. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  148. Tsuda, T.; Horio, F.; Uchida, K.; Aoki, H.; Osawa, T. Dietary cyanidin 3-O-β-Dglucoside rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J. Nutr. 2003, 133, 2125–2130. [Google Scholar] [CrossRef] [PubMed]
  149. Tsuda, T.; Ueno, Y.; Kojo, H.; Yoshikawa, T.; Osawa, T. Gene expression profile of isolated rat adipocytes treated with anthocyanins. Biochim. Biophys. Acta 2005, 1733, 137–147. [Google Scholar] [CrossRef] [PubMed]
  150. Jayaprakasam, B.; Vareed, S.K.; Olson, L.K.; Nair, M.G. Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J. Agric. Food Chem. 2005, 53, 28–31. [Google Scholar] [CrossRef]
  151. Zhang, W.; Hong, D.; Zhou, Y.; Zhang, Y.; Shen, Q.; Li, J.Y.; Hu, L.H.; Li, J. Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake. Biochim. Biophys. Acta 2006, 1760, 1505–1512. [Google Scholar] [CrossRef]
  152. Capcarova, M.; Kalafova, A.; Schwarzova, M.; Schneidgenova, M.; Svik, K.; Prnova, M.S.; Slovak, L.; Kovacik, A.; Lory, V.; Zorad, S.; et al. Cornelian cherry fruit improves glycaemia and manifestations of diabetes in obese Zucker diabetic fatty rats. Res. Vet. Sci. 2019, 126, 118–123. [Google Scholar] [CrossRef]
  153. Dzydzan, O.; Bila, I.; Kucharska, A.Z.; Brodyak, I.; Sybirna, N. Antidiabetic effects of extracts of red and yellow fruits of cornelian cherries (Cornus mas L.) on rats with streptozotocin-induced diabetes mellitus. Food Funct. 2019, 16, 6459–6472. [Google Scholar] [CrossRef] [Green Version]
  154. Asgary, S.; Rafieian-Kopaei, M.; Adelnia, A.; Kazemi, S.; Shamsi, F. Comparing the effects of lovastatin and Cornus mas fruit on fibrinogen level in hypercholesterolemic rabbits. ARYA Atheroscler. 2010, 6, 1–5. [Google Scholar]
  155. Rafieian-Kopaei, M.; Asgary, S.; Adelnia, A.; Setorki, M.; Khazaei, M.; Kazemi, S.; Shamsi, F. The effects of cornelian cherry on atherosclerosis and atherogenic factors in hypercholesterolemic rabbits. J. Med. Plant Res. 2011, 5, 2670–2676. [Google Scholar]
  156. Fruchart, J.C. Peroxisome proliferator-activated receptor alpha (PPAR alpha): At the crossroads of obesity, diabetes and cardiovascular disease. Atherosclerosis 2009, 205, 1–8. [Google Scholar] [CrossRef] [PubMed]
  157. Kim, M.J.; Bae, G.S.; Jo, I.J.; Choi, S.B.; Kim, D.G.; Shin, J.Y.; Lee, S.K.; Kim, M.J.; Shin, S.; Song, H.J.; et al. Loganin protects against pancreatitisby inhibiting NF-kappaB activation. Eur. J. Pharmacol. 2015, 765, 541–550. [Google Scholar] [CrossRef] [PubMed]
  158. Xu, Y.D.; Cui, C.; Sun, M.F.; Zhu, Y.L.; Chu, M.; Shi, Y.W.; Lin, S.L.; Yang, X.S.; Shen, Y.Q. Neuroprotective effects of loganin on MPTP-Induced Parkinson’s disease mice: Neurochemistry, glialreaction and autophagy studies. J. Cell. Biochem. 2017, 118, 3495–3510. [Google Scholar] [CrossRef]
  159. Hwang, E.S.; Kim, H.B.; Lee, S.; Kim, M.J.; Lee, S.O.; Han, S.M.; Maeng, S.; Park, J.H. Loganin enhances long-term potentiation andrecovers scopolamine-induced learning and memory impair-ments. Physiol. Behav. 2017, 171, 243–248. [Google Scholar] [CrossRef]
  160. Kang, D.G.; Choi, D.H.; Lee, J.K.; Lee, Y.J.; Moon, M.K.; Yang, S.N.; Kwon, T.O.; Kwon, J.W.; Kim, J.S.; Lee, H.S. Endothelial NO/cGMP- dependent vascular relaxation of cornuside isolated from the fruit of Cornus officinalis. Planta Med. 2007, 73, 1436–1440. [Google Scholar] [CrossRef]
  161. Choi, Y.H.; Jin, G.Y.; Li, G.Z.; Yan, G.H. Cornuside suppresses lipopolysaccharideinduced inflammatory mediators by inhibiting nuclear factor- kappa B activation in RAW 264.7 macrophages. Biol. Pharm. Bull. 2011, 34, 959–966. [Google Scholar] [CrossRef] [Green Version]
  162. Kang, D.G.; Moon, M.K.; Lee, A.S.; Kwon, T.O.; Kim, J.S.; Lee, H.S. Cornuside suppresses cytokine-induced proinflammatory and adhesion molecules in the human umbilical vein endothelial cells. Biol. Pharm. Bull. 2007, 30, 1796–1799. [Google Scholar] [CrossRef] [Green Version]
  163. Recio, M.C.; Giner, R.M.; Manez, S.; Rios, J.L. Structural considerations on the iridoids as anti-inflammatory agents. Planta Med. 1994, 60, 232–234. [Google Scholar] [CrossRef]
  164. Gervois, P.; Mansouri, R.M. PPARα as a therapeutic target in inflammation associated diseases. Expert Opin. Ther. Targets 2012, 16, 1113–1125. [Google Scholar] [CrossRef]
  165. Lotfi, A.; Shahryar, H.A.; Rasoolian, H. Effects of cornelian cherry (Cornus mas L.) fruit on plasma lipids, cortisol, T3 and T4 levels in hamsters. J. Anim. Plant Sci. 2014, 24, 459–462. [Google Scholar]
  166. Mohammadi, K.; Sani, M.A.; Nattagh-Eshtivani, E.; Yaribash, S.; Rahmani, J.; Yancheshmeh, B.S.; McClements, D.J. A systematic review and meta-analysis of the impact of cornelian cherry consumption on blood lipid profiles. Food Sci. Nutr. 2021, 9, 4629–4638. [Google Scholar] [CrossRef] [PubMed]
  167. Park, C.H.; Cho, E.J.; Yokozawa, T. Protection against hypercholesterolemia by Corni fructus extract and its related protective mechanism. J. Med. Food 2009, 12, 973–981. [Google Scholar] [CrossRef] [PubMed]
  168. Yang, C.; Bao, X.; Zhang, L.; Li, Y.; Li, L.; Zhang, L. Cornel iridoid glycoside ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by attenuating amyloid-beta, tau hyperphosphorylation and neurotrophic dysfunction. Ann. Transl. Med. 2020, 8, 328. [Google Scholar] [CrossRef]
  169. Ma, D.L.; Luo, Y.; Huang, R.; Zhao, Z.R.; Zhang, L.; Li, Y.L.; Wang, Q.; Li, L.; Zhang, L. Cornel iridoid glycoside suppresses hyperactivity phenotype in rTg4510 mice through reducing tau pathology and improving synaptic dysfunction. Curr. Med. Sci. 2020, 40, 1031–1039. [Google Scholar] [CrossRef]
  170. Tian, W.; Zhao, J.; Lee, J.H.; Akanda, M.R.; Cho, J.H.; Kim, S.K.; Choi, Y.J.; Park, B.Y. Neuroprotective effects of Cornus officinalis on stress-induced hippocampal deficits in rats and H2O2-induced neurotoxicity in SH-SY5Y neuroblastoma cells. Antioxidants 2019, 9, 27. [Google Scholar] [CrossRef] [Green Version]
  171. Tian, J.S.; Liu, S.B.; He, X.Y.; Xiang, H.; Chen, J.L.; Gao, Y.; Zhou, Y.Z.; Qin, X.M. Metabolomics studies on corticosterone-induced PC12 cells: A strategy for evaluating an in vitro depression model and revealing the metabolic regulation mechanism. Neurotoxicol. Teratol. 2018, 69, 27–38. [Google Scholar] [CrossRef]
  172. Wang, X.; Liu, J.; Jin, N.A.; Xu, D.; Wang, J.; Han, Y.; Yin, N. Fructus Corni extract-induced neuritogenesis in PC12 cells is associated with the suppression of stromal interaction molecule 1 expression and inhibition of Ca2+ influx. Exp. Ther. Med. 2015, 9, 1773–1779. [Google Scholar] [CrossRef] [Green Version]
  173. Francik, R.; Kryczyk, J.; Krośniak, M.; Berköz, M.; Sanocka, I.; Francik, S. The neuroprotective effect of Cornus mas on brain tissue of wistar rats. Sci. World J. 2014, 2014, 847368. [Google Scholar] [CrossRef] [Green Version]
  174. Unsal, C.; Albayrak, Y.; Albayrak, N.; Kuloglu, M.; Hashimoto, K. Reduced serum paraoxonase 1 (PON-1) activity in patients with schizophrenia treated olanzapine but not quetiapine. Neuropsychiatr. Dis. Treat. 2013, 9, 1545–1552. [Google Scholar] [CrossRef] [Green Version]
  175. Jarvik, G.P.; Tsai, N.T.; McKinstry, L.A.; Wani, R.; Brophy, V.H.; Richter, R.J.; Schellenberg, G.D.; Heagerty, P.J.; Hatsukami, T.S.; Furlong, C.E. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 1329–1333. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  176. Huang, W.T.; Wang, W.; Ai, H.X.; An, Y.; Li, L.; Wang, Y.L. Influence of morroniside on the growth and protection against H2O2-induced cytotoxicity in SH-SY5Y nerve cells. Chin. J. Rehab Theory Pract. 2007, 13, 839–841. [Google Scholar]
  177. Sun, F.L.; Wang, W.; An, Y.; HX, A.; Zhang, L.; Li, L. Morroniside inhibits H2O2-induced oxidative injury in SH-SY5Y neuroblastoma cell. Chin. Rem. Clin. 2008, 8, 843–845. [Google Scholar]
  178. Sun, F.L.; Wang, W.; Zuo, W.; Xue, J.L.; Xu, J.D.; Ai, H.X.; Zhang, L.; Wang, X.M.; Ji, X.M. Promoting neurogenesis via Wnt/β-catenin signaling pathway accounts for the neurorestorative effects of morroniside against cerebral ischemia injury. Eur. J. Pharmacol. 2014, 738, 214–221. [Google Scholar] [CrossRef] [PubMed]
  179. Mamedov, N.; Craker, L.E. Cornelian cherry. A prospective source for phytomedicine. Acta Hortic. 2004, 629, 83–86. [Google Scholar] [CrossRef]
  180. Krzysciak, P.; Krosniak, M.; Gastol, M.; Ochonska, D.; Krzysciak, W. Antimicrobial activity of Cornelian cherry (Cornus mas L.). Postępy Fitoterapii 2011, 4, 227–231. [Google Scholar]
  181. Balcht, A.; Smith, R. Pseudomonas aeruginosa: Infections and treatment. Informa Health Care 1994, 2, 83–84. [Google Scholar]
  182. Hansson, C.; Faergemann, J. The effect of antiseptic solutions on microorganisms in venous leg ulcers. Acta Derm. Venereol. 1995, 75, 31–33. [Google Scholar] [CrossRef]
  183. Kyriakopoulos, A.M.; Dinda, B. Cornus mas (Linnaeus) novel devised medicinal preparations: Bactericidal effect against Staphylococcus aureus and Pseudomonas aeruginosa. Molecules 2015, 20, 11202–11218. [Google Scholar] [CrossRef] [Green Version]
  184. Tong, S.Y.; Davis, J.S.; Eichenberger, E.; Holland, T.L.; Fowler, V.G., Jr. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations and management. Clin. Microbiol. Rev. 2015, 28, 603–661. [Google Scholar] [CrossRef] [Green Version]
  185. Wu, V.C.; Qiu, X.; Peggy Hsieh, Y.H. Evaluation of Escherichia coli O157:H7 in apple juice with Cornus fruit (Cornus officinalis Sieb. et Zucc.) extract by conventional media and thin agar layer method. Food Microbiol. 2008, 25, 190–195. [Google Scholar] [CrossRef] [PubMed]
  186. Yousefi, B.; Abasi, M.; Abbasi, M.M.; Jahanban-Esfahlan, R. Anti-proliferative properties of Cornus mas fruit in different human cancer cells. Asian Pac. J. Cancer Prev. 2015, 16, 5727–5731. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  187. Chang, J.; Chiang, L.; Hsu, F.; Lin, C. Chemoprevention against hepatocellular carcinoma of Cornus officinalis in vitro. Am. J. Chin. Med. 2004, 32, 717–725. [Google Scholar] [CrossRef] [PubMed]
  188. Alavian, S.M.; Banihabib, N.; Haghi, M.E.; Panahi, F. Protective effect of Cornus mas fruits extract on serum biomarkers in CCl4- induced hepatotoxicity in male rats. Hepat. Mont. 2014, 14, e10330. [Google Scholar] [CrossRef] [Green Version]
  189. Es Haghi, M.E.; Dehghan, G.; Banihabib, N.; Zare, S.; Mikaili, P.; Panahi, F. Protective effects of Cornus mas fruit extract on carbon tetrachloride induced nephrotoxicity in rats. Indian J. Nephrol. 2014, 24, 291–296. [Google Scholar] [CrossRef]
  190. Abdollahi, B.; Abbasi, M.M.; Milani, P.Z.; Nourdadgar, A.S.; Khojasteh, S.M.B.; Nejati, V. Hydro-methanolic extract of Cornus mas L. and blood glucose, lipid profile, and hematological parameters of male rats. Iran. Red. Crescent. Med. J. 2014, 16, e17784. [Google Scholar] [CrossRef] [Green Version]
  191. Vagdatli, E.; Gounari, E.; Lazaridou, E.; Katsibourlia, E.; Tsikopoulou, F.; Labrianou, I. Platelet distribution width: A simple, practical and specific marker of activation of coagulation. Hippokratia 2010, 14, 28–32. [Google Scholar]
  192. Eshaghi, M.E.; Zare, S.; Banihabib, N.; Nejati, V.; Farokhi, F.; Mikaili, P. Cardioprotective effect of Cornus mas fruit extract against carbon tetrachloride induced-cardiotoxicity in albino rats. J. Basic Appl. 2012, 2, 11106–11114. [Google Scholar]
  193. Xu, J.J.; Li, R.J.; Zhang, Z.H.; Yang, C.; Liu, S.X.; Li, Y.L.; Chen, M.W.; Wang, W.W.; Zhang, G.Y.; Song, G.; et al. Loganin Inhibits Angiotensin II–Induced Cardiac Hypertrophy through the JAK2/STAT3 and NF-κB Signaling Pathways. Front. Pharmacol. 2021, 12, 678886. [Google Scholar] [CrossRef]
  194. Cui, Y.; Wang, Y.; Zhao, D.; Feng, X.; Zhang, L.; Liu, C. Loganin Prevents BV-2 Microglia Cells from Aβ1-42 -induced Inflammation via Regulating TLR4/TRAF6/NF-κB axis. Cell Biol. Int. 2018, 42, 1632–1642. [Google Scholar] [CrossRef]
  195. Liu, S.; Shen, H.; Li, J.; Gong, Y.; Bao, H.; Zhang, J.; Hu, L.; Wang, Z.; Gong, J. Loganin Inhibits Macrophage M1 Polarization and Modulates sirt1/NF-κB Signaling Pathway to Attenuate Ulcerative Colitis. Bioengineered 2020, 11, 628–639. [Google Scholar] [CrossRef] [PubMed]
  196. Wang, J.W.; Pan, Y.B.; Cao, Y.Q.; Wang, C.; Jiang, W.D.; Zhai, W.F.; Lu, J.G. Loganin Alleviates LPS-activated Intestinal Epithelial Inflammation by Regulating TLR4/NF-κB and JAK/STAT3 Signaling Pathways. Kaohsiung J. Med. Sci. 2020, 36, 257–264. [Google Scholar] [CrossRef] [PubMed]
  197. Yuan, J.; Cheng, W.; Zhang, G.; Ma, Q.; Li, X.; Zhang, B.; Hu, T.; Song, G. Protective Effects of iridoid glycosides on acute colitis via inhibition of the inflammatory response mediated by the STAT3/NF-lB Pathway. Int. Immunopharmacol. 2020, 81, 106240. [Google Scholar] [CrossRef] [PubMed]
  198. Chiou, S.H.; Chang, C.J.; Hsu, W.M.; Kao, C.L.; Liu, J.H.; Chen, W.L.; Tsai, D.C.; Wu, C.C.; Chou, C.K. Elevated nitric oxide level in aqueous humor of patients with acute angle- closure glaucoma. Ophthalmologica 2001, 215, 113–116. [Google Scholar] [CrossRef]
  199. Lv, T.; Xu, M.; Wang, D.; Zhu, H.T.; Yang, C.R.; Zhang, T.T.; Zhang, Y.J. The chemical constituents from the roots of Gentiana crassicaulis and their inhibitory effects on inflammatory mediators NO and TNF-α. Nat. Prod. Bioprospect. 2012, 2, 217–221. [Google Scholar] [CrossRef] [Green Version]
  200. Kim, J.Y.; Kim, Y.K.; Choi, M.K.; Oh, J.; Kwak, H.B.; Kim, J.J. Effect of Cornus officinalis on receptor activator of nuclear factor-kappaB ligand (RANKL)-induced osteoclast differentiation. J. Bone Metab. 2012, 19, 121–127. [Google Scholar] [CrossRef] [Green Version]
  201. Cheng, L.; Zeng, G.; Liu, Z.; Zhang, B.; Cui, X.; Zhao, H.; Xia, C. Protein kinase B and extracellular signal-regulated kinase contribute to the chondroprotective effect of morroniside on osteoarthritis chondrocytes. J. Cell. Mol. Med. 2015, 19, 1877–1886. [Google Scholar] [CrossRef]
  202. Kim, S.H.; Kim, B.K.; Lee, Y.C. Effects of Corni fructus on ovalbumin induced airway inflammation and airway hyper-responsiveness in a mouse model of allergic asthma. J. Inflamm. 2012, 9, 9. [Google Scholar] [CrossRef] [Green Version]
  203. Du, W.; Cai, H.; Wang, M.; Ding, X.; Yang, H.; Cai, B. Simultaneous determination of six active components in crude and processed Fructus Corni by high performance liquid chromatography. J. Pharm. Biomed. Anal. 2008, 48, 194–197. [Google Scholar] [CrossRef]
  204. Gholamrezayi, A.; Aryaeian, N.; Rimaz, S.; Abolghasemi, J.; Fallah, S.; Moradi, N.; Taghizadeh, M. The effect of Cornus mas fruit extract consumption on lipid profile, glycemic indices, and leptin in postmenopausal women- a randomized clinical trial. Phytother. Res. 2019, 33, 2979–2988. [Google Scholar] [CrossRef]
  205. Asgary, S.; Kelishadi, R.; Rafieian-Kopaei, M.; Najafi, S.; Najafi, M.; Sahebkar, A. Investigation of the lipid-modifying and antiinflammatory effects of Cornus mas L. supplementation on dyslipidemic children and adolescents. Pediatric Cardiol. 2013, 34, 1729–1735. [Google Scholar] [CrossRef] [PubMed]
  206. Klymenko, S.; Kucharska, A.Z.; Sokół-Łetowska, A.; Piórecki, N.; Przybylska, D.; Grygorieva, O. Iridoids, Flavonoids, and antioxidant capacity of Cornus mas, C. officinalis, and C. mas × C. officinalis fruits. Biomolecules 2021, 11, 776. [Google Scholar] [CrossRef] [PubMed]
Table
Table 1. Traditional uses of Cornus fruits species.
Table 1. Traditional uses of Cornus fruits species.
Traditional UseCountryReference
C. masImmune system strengtheningSerbia[21]
FeverAlbania[22]
Iran[17]
Slovakia[15]
Romania[23]
Tuberculosis digestiveGreece[24]
CholeraArmenia[25]
Measles, chicken poxAzerbaijan, Russia[12,14]
VermifugeRomania[23]
MalariaIran[17]
CancerIran[17]
HeadacheCroatia[22]
Sore throatAzerbaijan, Russia[12,14]
Colds and fluTurkey[26]
Asthmatic problemsAlbania[22]
CoughTurkey[27]
BronchitisTurkey[28]
Gastrointestinal disorders and inflammation Turkey[18]
Greece[24]
Slovakia[15]
Albania[22]
Serbia[21]
Azerbaijan, Russia[12,14]
Bowel diseaseIran[17]
Stomach ulcers and colitisIran, Azerbaijan, Armenia, Georgia and Turkey[12,13,14]
Dyspepsia and colitisItaly[29]
DiarrhoeaIran[17]
Serbia[30,31]
Romania[23]
Azerbaijan[32]
Bosnia-Herzegovina[33]
LaxativeSerbia[30]
Turkey[34]
Urinary inflammationIran[17]
Turkey[26]
Excessive urination USA[35]
Kidney functionChina[36]
Kidney infectionIran[17]
Kidney stonesAlbania[37]
Iran[17]
SweatingUSA[35]
Wound healingIran, Azerbaijan, Armenia, Georgia and Turkey[12,13,14]
Skin diseasesGreece[24]
Bosnia-Herzegovina[33]
SunstrokeIran[17]
Bruises Croatia[22]
AnaemiaKosova[38]
Greece[24]
Serbia[21]
Azerbaijan, Russia[12,14]
Blood circulationKosova[38]
Menstrual bleedingUSA[35]
Greece[24]
Bosnia-Herzegovina[33]
Kosova[38]
China[39]
RheumatismKosova[38]
Albania[37]
RicketsAzerbaijan, Russia[12,14]
GoutGreece[24]
AppetizerItaly[40]
ObesityCroatia[22]
DiabetesUkraine, Russia[41]
Cosmetics to exert favourable human complexionItaly[42]
C. sanguineaDiarrhoeaTurkey[19]
Gastrointestinal disordersTurkey[20]
Stomachaches, sore eyesTurkey[20]
Sore throatsTurkey[20]
AstringentItaly[40]
C. officinalisDizzinessChina[43]
GlaucomaChina[44]
CataractChina[44]
TinnitusChina[43,44]
Sore throatChina[44]
AstringentChina[44]
CoughChina[44]
Asthmatic problemsChina[44]
Strengthening spleen and kidneyChina[44]
Excessive urination and polydipsiaChina[9]
Chronic nephritisChina[44]
Kidney and liver function, tonicChina[8]
Menstrual bleedingChina[45]
DiabetesChina[44]
Weakness of the waist, kneesChina[43]
Arresting seminal emissionChina[44]
ImpotenceChina[44]
SpermatorrhoeaChina[9]
Night sweatsChina[44]
Threatened abortionChina[44]
C. controversaAstringent
Tonic		Korea and China[46]
C. kousaDiarrhoea
Haemostatic agent		Korea
Korea		[47]
[47]
Table
Table 2. The main flavonoids and proanthocyanidins of Cornus fruits.
Table 2. The main flavonoids and proanthocyanidins of Cornus fruits.
Chemical ConstituentC. masC. sanguineaC. officinalisC. kousaReference
Flavonoids
Ampelopsin 3-O-glucoside ✓ [58]
Aromadendrin✓ [63]
Aromadendrin 7-O-glucoside✓ [50]
4-Acetoxy-5,2′,4′,6′-β-pentahydroxy-3-methoxychalcone✓ [63]
Catechin✓ [49,50]
Epicatechin✓ [49]
Epicatechin 3-O-gallate ✓ [60]
7,3′-dihydroxy-5,4′-dimethoxyflavanone✓ [63]
Isorhamnetin 3-O-glucuronide ✓ [58]
Isorhamnetin hexoside ✓[57]
Kaempferide ✓ [60]
Kaempferol ✓✓[59,62]
Kaempferol 3-O-galactoside✓ ✓ [50,64]
Kaempferol 3-O-glucoside✓ ✓✓[49,50,59,61,62]
Kaempferol 3-O-rhamnoside ✓[61]
Kaempferol 3-O-rutinoside ✓ [8]
Myricetin✓ [65]
Myricetin 3-galactoside✓ [66]
Myricetin 3-O-rhamnoside ✓[61]
Myricetin 3-O-α-L-arabinopyranoside-4′-O-β-D-glucopyranoside ✓ [58]
Naringenin ✓ [59]
Naringenin 3-O-methyl ester✓ [65]
Isoquercitrin ✓ [60]
Quercetin✓ ✓ [59,67]
Quercetin 3-O-galactoside (hyperoside)✓✓✓✓[20,50,57,58,60,62,64]
Quercetin 3-O-(6″-acetyl)galactoside (methyl ester) ✓✓[8,57]
Quercetin 3-O-galactopyranoside 4′-O-glucopyranoside✓✓✓✓[20,49,50,57,58,64]
Quercetin 3-O-glucoside✓ ✓✓[8,50,62]
Quercetin 3-O-(6″-acetyl)glucoside ✓[57]
Quercetin 3-O-(6″-acetyl)hexoside ✓[57]
Quercetin 3,4′-di-O-glucoside ✓ [58]
Quercetin 3-O-glucuronide (querciturone)✓✓✓ [20,49,50,58,60]
Quercetin 3-O-glucuronide methyl ester ✓ [64]
Quercetin 3-O-(6″-n-butyl glucuronide) ✓ [60]
Quercetin-3-O-(6″-malonyl)hexoside 1 and 2 ✓[57]
Quercetin 3-O-rhamnoside✓✓ [20,50]
Quercetin 3-O-rhamnosyl-(1→6)-galactopyranoside ✓ [64]
Quercetin 3-O-robinobioside✓ [65]
Quercetin 3-O-rutinoside (rutin)✓✓✓ [20,49,50,58,64]
Quercetin 3-O-xyloside✓ ✓[50,57]
Proanthocyanidins
Epicatechin- 4,8-epicatechin (Procyanidin B2)✓ [49]
Table
Table 3. The main anthocyanins are identified in Cornus fruits.
Table 3. The main anthocyanins are identified in Cornus fruits.
Chemical ConstituentC. masC. sanguineaC. officinalisC. controversaC. kousaReference
Cyanidin 3-O-galactoside✓ ✓✓✓[2,11,50,57,64,66,68,69,70]
Cyanidin 3-O-glucoside✓✓ ✓✓[11,50,57,66,68,69,70,71]
Cyanidin 3-O-robinobioside✓ [50,66,68,69,70]
Cyanidin 3-O-rutinoside✓ [50,66,68,69,70]
Delphinidin-3-O-galactoside✓ ✓✓ [2,11,50,64,66,68,69,70]
Delphinidin 3-O-glucoside✓ ✓✓[2,11,57,64,70]
Delphinidin 3-O-rutinoside ✓ [11]
Pelargonidin 3-O-galactoside✓ ✓✓✓[2,11,50,57,64,66,68,69,70]
Pelargonidin 3-O-glucoside✓ [50,66,68,69,70]
Pelargonidin 3-O-robinobioside✓ [50,66,68,69,70]
Pelargonidin 3-O-rutinoside✓ [50,66,68,69,70]
Peonidin 3-O-glucoside✓ [50,66,68,69,70]
Petunidin 3-O-glucoside✓ [66]
Table
Table 4. The main lignans of Cornus fruits.
Table 4. The main lignans of Cornus fruits.
Chemical ConstituentC. officinalisC. kousaReference
(7S,8R)- Dihydrodehydrodiconiferyl alcohol✓✓[51,55]
(7S,8R)-5-Methoxydihydrodehydroconiferyl alcohol✓ [51]
(7S,8R)-Urolignoside= (7S,8R)-dihydrodehydrodiconiferyl alcohol-4-O-β-D-glucopyranoside✓ [51]
(7S,8R)-Dihydrodehydrodiconiferyl alcohol-9-β-D-glucopyranoside✓ [51]
(7S,8R)-Dihydrodehydrodiconiferyl alcohol-9′-β-D-glucopyranoside ✓ [51]
(-)-Balanophonin ✓[56]
Cornuskoside A = (7′S, 8′R)-dihydrodehydrodiconiferyl alcohol-4′-O-β-D-xylopyranoside, ✓[56]
Officinalignan A = (7S,8R)-4,3′,9′-trihydroxyl-3,3′-dimethoxyl-7,8- dihydrobenzofuran-1′-propylneolignan-9-O-(6-O-galloyl)-β-D-glucopyranoside✓ [51]
d-Pinoresinol✓ [51]
Medioresinol✓ [51]
Syringaresinol✓ [51]
(+)-Pinoresinol ✓[55]
Pinoresinol O-β-D-glucopyranoside✓ [51]
Epi-pinoresinol✓ [51]
Epi-syringaresinol✓ [51]
(+)-Lariciresinol ✓[55,72]
(+)-Isolariciresinol✓ [51]
Isolariciresinol 9-O-β-D-glucopyranoside✓ [51]
Secoisolariciresinol 9-O-β-D-glucopyranoside✓ [51]
Dimethyl 3,3′,4,4′-tetrahydroxy-δ-truxinate✓ [51]
Officinalignan B✓ [51]
Threo-Guaiacylglycerol-β-coniferyl aldehyde ether ✓[55]
Erythreo-Guaiacylglycerol-β-coniferyl aldehyde ether ✓[55]
Table
Table 5. The main acids and phenolic acids of Cornus fruits.
Table 5. The main acids and phenolic acids of Cornus fruits.
Chemical ConstituentC. masC. sanguineaC. officinalisC. kousaReference
Acids and esters
2-Butoxybutanedioic acid ✓ [64,84]
Citric acid✓ ✓✓[57,65,79,80,86]
Fumaric acid✓ ✓[57,65,79,80]
Isocitric acid✓ [65,79,80]
Dimethylmalate ✓ [64]
Maleic acid✓ [65,79,80]
Malic acid✓ ✓✓[57,64,75]
Butyl malic acid ✓ [64]
Malonic acid✓ [65,79,80]
Oxalic acid✓ ✓[57,65,79,80]
3-Hydroxy-2,4-di-amino-pentanoic acid ✓ [64]
Methyl quinate ✓ [64]
Quinic acid✓ [65,79,80]
Shikimic acid✓ ✓[57,65,79,80]
Succinic acid✓ ✓ [65,79,80,86]
Tartaric acid✓ ✓ [64,65,79,80]
Arjunolic acid ✓[47]
Arjunglucoside II ✓ [64]
Asiatic acid ✓[47]
19-Hydroxyasiatic acid ✓[47]
Betulinic acid ✓✓[47,64]
Corosolic acid ✓[87]
Maslinic acid ✓[87]
Oleanic acid ✓[88]
Pimaric acid ✓ [89]
Tormentic acid ✓[47]
Ursolic acid✓ ✓✓[47,69,90]
2α-Hydroxylursolic acid ✓[87]
Phenolic acids and esters
3,5-Dihydroxybenzoic acid ✓ [64]
2-O-(4-Hydroxybenzoyl)-2,4,6-trihydroxyphenyl-methylacetate ✓ [64]
Caffeic acid✓ ✓ [64,75]
4-Caffeoylquinic acid ✓[57]
Caffeoyltartaric acid dimethyl ester ✓ [85]
Caftaric acid monomethylester ✓ [60]
Chlorogenic acid✓ ✓[49,52,57,82]
Neochlorogenic acid✓✓ ✓[49,52,57,71,82,91]
p-Hydroxycinnamic acid ✓ [64]
Coroffester A-D ✓ [92]
p-Coumaric acid✓ ✓ [64,81]
Ellagic acid✓ ✓ [49,52,64]
Ferulic acid✓ [53]
Gallic acid✓ [49,52]
Methyl gallate ✓ [64]
3,5-Dihydroxy-2-(2-methoxy-2-oxoethyl) phenyl 4-hydroxybenzoate ✓ [8]
Protocatechuic acid✓ ✓ [64,75]
Rosmarinic acid✓ [75]
Salicylic acid✓ [75]
Sinapic acid✓ [75]
Syringic acid✓ [75]
Vanillic acid✓ [53]
Table
Table 6. The main iridoids of Cornus fruits.
Table 6. The main iridoids of Cornus fruits.
Chemical ConstituentOther NameC. officinalisC. masReference
Aglycons
Dehydro-morroniside aglycone ✓ [60,64]
(3S, 4R, 5S, 7S, 8R, 9R) Cornusfural A (with a 5-hydroxymethylfurfural group at C-3) ✓ [97]
(3R, 4R, 5S, 7S, 8R, 9R) Cornusfural B (with 5-hydroxymethylfurfural group at C-3) ✓ [97]
(1R, 3R, 4R, 5S, 7S, 8S, and 9R). Cornusfural C (with 5-hydroxymethylfurfural group at C-1 and C-3) ✓ [97]
Other iridoids
Catalposide ✓[67]
Cornuside ✓✓[8,52,60,82,98]
3′′,5′′-Dehydroxycornuside ✓ [99]
Demethoxycornuside ✓ [100]
Kingiside ✓ [60]
2′-O-p-Coumaroyl-kingiside ✓ [51,101]
Loganin ✓✓[8,52,82,98]
Loganin acid ✓✓[8,52,82,102]
7-O-Methylloganic acid ✓ [103]
Loganin-7-O-1′-malate Logmalicid A✓ [8]
Loganin-7-O-4′-malateLogmalicid B✓ [8]
2ʹ-O-p-Coumaroylloganin ✓ [51]
8-Epiloganin ✓ [104]
Secoxyloganin ✓ [8,60]
Secologanoside ✓ [60,100]
SecoxyloganinLoniceroside [105]✓ [100]
Sweroside ✓✓[52,82,106]
Swertiamarin ✓ [107,108]
VerbenalinCornin *✓ [64,101]
Morronisides
7-α-Morroniside ✓ [105]
7-β-Morroniside ✓ [105]
7-α-O-methyl-morroniside ✓ [100]
7-β-O-Methyl-morroniside ✓ [64,100,105]
7-α-O-Ethyl-morroniside ✓ [64]
7-β-O-Ethyl-morroniside ✓ [64]
7-O-Butyl-morroniside ✓ [64,109]
7-β-O-Dimethyl butanedioate morroniside ✓ [85]
7-α-O-Ethyl-4′,6′-O-(2′″hydroxymethylfuran 5″methylidene)-morronisideCornusfuroside A✓ [110]
7-β-O-Ethyl-4′,6′-O-(2′″hydroxymethylfuran 5″methylidene)-morronisideCornusfuroside B (isomer 1″S)✓ [110]
7-β-O-Ethyl-4′,6′-O-(2′″hydroxymethylfuran-5″methylidene)-morronisideCornusfuroside C(isomer 1″R)✓ [110]
7-β-O-(5″Methylfurfural)-4′,6′-O-(2′″hydroxymethylfuran-5″methylidene)-morronisideCornusfuroside D(1″R)✓ [110]
7-β-O-(5″Methylfurfural)-6′-O-(phenyllactic acid)-morroniside Cornusphenoside A✓ [111]
7-α-O-(5″Methylfurfural)-6′-O-(phenyllactic acid)-morronisideCornusphenoside B✓ [111]
6′-O-(Phenyllactic acid)-7-β-O-methyl-morronisideCornusphenoside C✓ [111]
6′-O-(Phenyllactic acid)-7- α-O-methyl-morronisideCornusphenoside D✓ [111]
7-β-O-(p-Hydroxyphenyl) propyl-1- α-morronisideCornusphenoside E✓ [112]
7-β-O-(p-Hydroxyphenyl) ethyl- morronisideCornusphenoside F✓ [112]
7-α-O-(p-Hydroxyphenyl) ethyl-morronisideCornusphenoside G✓ [112]
7- β-O-(2′Hydroxymethyl-5′methylfuran)-morronisideCornusphenoside H✓ [112]
7-β-O-(5′Methylfurfural)-morronisideCornusphenoside I✓ [112]
Morronisides glycosides
Methylquinate(1′-O-7-α)-morronisideCornusglucoside A✓ [113]
Glycerol-(1′-O-7-α)-morronisideCornusglucoside B✓ [113]
Diglycosides
β-D-Fructofuranosyl-(6″-O-7-β)-morronisideCornusdiglycoside A ✓ [114]
β-D-Fructofuranosyl-(6″-O-7-α) morronisideCornusdiglycoside B✓ [114]
β-D-Fructofuranosyl-(1″-O-7-α) morronisideCornusdiglycoside C✓ [114]
α-D-Fructofuranosyl-(6″-O-7-β)-morronisideCornusdiglycoside D✓ [114]
(6′-O-2″)- Fructopyranosyl-7α-O-methylmorroniside Cornusdiglycoside E✓ [114]
(6′-O-2″)- Fructopyranosyl-7β-O-methylmorronisideCornusdiglycoside F✓ [114]
α-D-Glucopyranosyl-(1″-O-7-α)-morronisideCornusdiglycoside G✓ [114]
α-D-Glucopyranosyl-(1″-O-7-β)-morronisideCornusdiglycoside H✓ [114]
α-D-Glucopyranosyl-(2″-O-7-β)-morronisideCornusdiglycoside I✓ [114]
β-D-Glucopyranosyl-(2″-O-7-β)-morronisideCornusdiglycoside I✓ [114]
α-D-Glucopyranosyl-(6″-O-7-β)-morronisideCornusdiglycoside J✓ [114]
β-D-Glucopyranosyl-(6″-O-7-β)-morronisideCornusdiglycoside J✓ [114]
Dimers (morroniside-morroniside)
7β-O-Methylmorroniside-(6′-O-7″)-α-morronisideCornuside J✓ [104]
7β-O-Methylmorroniside-(6′-O-7″)-β-morronisideCornuside A✓ [104]
7α-O-Methylmorroniside-(6′-O-7″)-β-morronisideCornuside E✓ [104]
7α-O-Methylmorroniside-(6′-O-7″)-α-morronisideCornuside G✓ [104]
7β-O-Methylmorroniside-(2′-O-7″)-α-morronisideCornuside I✓ [104]
7β-O-Methylmorroniside-(2′-O-7″)-β-morronisideCornuside B✓ [104]
7α-O-Methylmorroniside-(2′-O-7″)-α-morronisideCornuside H✓ [104]
7β-O-Methylmorroniside-(3′-O-7″)-β-morronisideCornuside C✓ [104]
7α-O-Methylmorroniside-(3′-O-7″)-β-morronisideCornuside F✓ [104]
7β-O-Methylmorroniside-(4′-O-7″)-β-morronisideCornuside D✓ [104]
7α-O-Ethylmorroniside-(6′-O-7″)-β-morronisideCornuside K ✓ [104]
7β-O-Ethylmorroniside-(6′-O-7′′)-β-morronisideWilliamsoside D✓ [104]
Dimers (cornuside-morroniside)
Cornuside-(2′-O- 7′′′)-β-morronisideCornusdiridoid A✓ [99]
Cornuside-(2′-O-7′′′)-α-morronisideCornusdiridoid B ✓ [99]
Cornuside-(3′-O-7′′′)-α-morronisideCornusdiridoid C✓ [99]
Cornuside-(4′-O-7′′′)-α-morronisideCornusdiridoid D✓ [99]
Cornuside-(6-O-7′′′)-β-morroniside Cornusdiridoid E✓ [99]
Cornuside-(6′-O-7′′′)-α-morronisideCornusdiridoid F✓ [99]
Dimers (loganin-morroniside)
Loganin-(6′-O-7″)-α-morronisideCornuside L✓ [104]
Loganin-(2′-O-7″)-α-morronisideCornuside M✓ [104]
Loganin-(4′-O-7″)-β-morronisideCornuside N✓ [104]
Loganin-(4′-O-7″)-α-morroniside ✓ [51,105]
Loganin-(7-O-7″)-β-morronisideCornuside O✓ [104]
Monoterpene indol alkaloid from C. officinalis
3β(R)-Vincosamide ✓ [99]
7-epi-Javaniside ✓ [99]
Javaniside ✓ [99]
* also identified in C. kousa [61].
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Tenuta, M.C.; Deguin, B.; Loizzo, M.R.; Cuyamendous, C.; Bonesi, M.; Sicari, V.; Trabalzini, L.; Mitaine-Offer, A.-C.; Xiao, J.; Tundis, R. An Overview of Traditional Uses, Phytochemical Compositions and Biological Activities of Edible Fruits of European and Asian Cornus Species. Foods 2022, 11, 1240. https://doi.org/10.3390/foods11091240

AMA Style

Tenuta MC, Deguin B, Loizzo MR, Cuyamendous C, Bonesi M, Sicari V, Trabalzini L, Mitaine-Offer A-C, Xiao J, Tundis R. An Overview of Traditional Uses, Phytochemical Compositions and Biological Activities of Edible Fruits of European and Asian Cornus Species. Foods. 2022; 11(9):1240. https://doi.org/10.3390/foods11091240

Chicago/Turabian Style

Tenuta, Maria C., Brigitte Deguin, Monica R. Loizzo, Claire Cuyamendous, Marco Bonesi, Vincenzo Sicari, Lorenza Trabalzini, Anne-Claire Mitaine-Offer, Jianbo Xiao, and Rosa Tundis. 2022. "An Overview of Traditional Uses, Phytochemical Compositions and Biological Activities of Edible Fruits of European and Asian Cornus Species" Foods 11, no. 9: 1240. https://doi.org/10.3390/foods11091240

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop